Document:

​
​

Exhibit 10.11
NOTE AND WARRANT PURCHASE AGREEMENT
This Note and Warrant Purchase Agreement, dated as of July 1, 2021 (this “Agreement”), is entered into by and among tsu Inc. (d/b/a display), a Delaware corporation (the “Company”), the persons and entities listed on the schedule of investors attached hereto as Schedule I (each a “Lender” and, collectively, the “Lenders”), as such Schedule I may be amended in accordance with Section 7 hereof, and Black, Inc., a Ontario corporation, as collateral agent (in such capacity, the “Collateral Agent”).
RECITALS
A.On the terms and subject to the conditions set forth herein, each Lender is willing to purchase from the Company, and the Company is willing to sell to such Lender, a secured promissory note in the principal amount set forth opposite such Lender’s name on Schedule I, together with a related warrant to acquire shares of the Company’s capital stock.
B.Capitalized terms not otherwise defined herein shall have the meaning set forth in the form of Note (as defined below) attached hereto as Exhibit A.
AGREEMENT
NOW THEREFORE, in consideration of the foregoing, and the representations, warranties, and conditions set forth below, the parties hereto, intending to be legally bound, hereby agree as follows:
1.The Notes and Warrants.
(a)Issuance of Notes. Subject to all of the terms and conditions hereof, the Company agrees to issue and sell to each of the Lenders, and each of the Lenders severally agrees to purchase, one or more secured promissory notes in the form of Exhibit A hereto (each, a “Note” and, collectively, the “Notes”) in the principal amount set forth opposite the respective Lender’s name on Schedule I.  The Company will have the right to require Lenders to purchase the Notes in one installment for all of the principal amount set forth opposite the respective Lender’s name on Schedule I or in multiple installments, in the discretion of the Company.  If the Company elects more than one installment, the Lender will purchase Notes within two (2) business days of written demand from the Company in the principal amount demanded; provided that the aggregate of all such installments shall not exceed the principal amount set forth opposite the respective Lender’s name on Schedule I (the “Lender’s Maximum Obligation”). The obligations of the Lenders to purchase Notes are several and not joint and, notwithstanding anything to the contrary contained herein, shall not exceed such Lender’s Maximum Obligation. The aggregate principal amount for all Notes issued hereunder shall not exceed $30,000,000.
(b)Security Agreement. The Collateral Agent will execute a security agreement with the Company in the form of Exhibit B hereto, granting to the Collateral Agent for the benefit of the Lenders a security interest over substantially all of the Company’s assets (the “Security Agreement”). In order to expedite the transactions contemplated by this Agreement, Black, Inc. is hereby appointed to act as Collateral Agent on behalf of the Lenders. Each of the Lenders, and each assignee of any Lender, hereby irrevocably authorizes the Collateral Agent to take such actions on behalf of such Lender, and to exercise such powers as are specifically delegated to the Collateral Agent by the terms and provisions set forth in the Security Agreement and the Notes, together with such actions and powers as are reasonably incidental thereto.
		(i)	Each Lender, by its acceptance of the benefits of the Collateral and of the Secured Obligations (as such terms are defined in the Security Agreement), agrees (a) to reimburse the Collateral Agent, on demand, in the amount of its pro rata

​

​

 share (based on the sum of its aggregate available outstanding Notes) of any expenses incurred for the benefit of the Lenders by the Collateral Agent, including reasonable counsel fees, that shall not have been reimbursed by the Company (and without limiting any the Company’s obligation to do so) and (b) to indemnify and hold harmless the Collateral Agent and any of its directors, officers, employees or agents, in the amount of such pro rata share, from and against any and all liabilities, taxes, obligations, losses, damages, penalties, actions, judgments, suits, costs, expenses or disbursements of any kind or nature whatsoever that may be imposed on, incurred by or asserted against it in its capacity as the Collateral Agent or any of them in any way relating to or arising out of the Transaction Documents, or any action taken or omitted by it or any of them under the Transaction Documents, to the extent the same shall not have been reimbursed by the Company (and without limiting any the Company’s obligation to do so); provided, however, that the Company shall be liable to the Collateral Agent or any such other indemnified person for any portion of such liabilities, obligations, losses, damages, penalties, actions, judgments, suits, costs, expenses or disbursements are determined by a court of competent jurisdiction by final and non-appealable judgment to have resulted from the gross negligence or willful misconduct of the Collateral Agent or any of its directors, officers, employees or agents.
(ii)Each Lender, by its acceptance of the benefits of the Collateral and of the Secured Obligations provided under the Security Agreement, acknowledges that it has, independently and without reliance upon the Collateral Agent or any other Lender and based on such documents and information as it has deemed appropriate, made its own credit analysis and decision to enter into the Transaction Documents. Each Lender also acknowledges that it will, independently and without reliance upon the Collateral Agent or any other Lender and based on such Transaction Documents and information as it shall from time to time deem appropriate, continue to make its own decisions in taking or not taking action under or based upon the Transaction Documents or any other loan document, any related agreement or any document furnished hereunder or thereunder.
(iii)Without limiting the foregoing, no Lender shall have any right individually to realize upon any of the Collateral or to enforce the Secured Obligations, it being understood and agreed that all powers, rights and remedies under this Agreement may be exercised solely by the Collateral Agent on behalf of the Lenders in accordance with the terms of the Security Agreement. In the event of a foreclosure by the Collateral Agent on any of the Collateral pursuant to a public or private sale or other disposition, any Lender may be the purchaser of any or all of such Collateral at any such sale or other disposition, and the Collateral Agent, as agent for and representative of the Lender (but not any Lender in its individual capacity) shall be entitled, for the purpose of bidding and making settlement or payment of the purchase price for all or any portion of the Collateral sold at any such sale, to use and apply any of the Secured Obligations as a credit on account of the purchase price for any Collateral payable by the Collateral Agent for the benefit of the Lenders at such sale or other disposition. Each Lender, by its acceptance of the benefits of the Collateral and of the Secured Obligations provided under this Agreement, to have agreed to the foregoing provisions. The provisions of this paragraph are for the sole benefit of the Collateral Agent and shall not afford any right to, or constitute a defense available to, any Lender.
​

-2-
​

​

(c)Issuance of Warrants. Concurrently with the issuance of each Note to the Lenders, the Company will issue to each Lender a warrant to acquire common shares of the Company, par value $0.001 (“Common Shares”) in the form attached hereto as Exhibit C (each, a “Warrant” and, collectively, the “Warrants”) for a number of Common Shares equal to fifteen percent (15%) of the principal amount of each Note (calculated based on a $250 million equity valuation and the actual number of outstanding Common Shares on the day immediately preceding the date of the Note) at the purchase price set forth opposite each Lender’s name on Schedule I hereto; provided that if the Company elects to receive such principal amount in more than one installment, Lender will receive on the first installment date a Warrant for number of shares equal to fifteen percent (15%) of the entire principal amount set forth opposite such Lender’s name on Schedule I rather than the principal amount of the Note issued at such installment, and such Lender will not receive additional Warrants for Notes issued in the subsequent installments.
(d)Funding Fee.  Each Lender will earn a closing fee in an amount equal to one percent (1%) of the principal amount of each Note funded.  This funding fee shall be accrued and payable upon maturity or earlier pre-payment.
(e)Delivery. The sale and purchase of the Notes and Warrants shall take place at a closing (the “Closing”) to be held at such place and time as the Company and the Lenders may determine (the “Closing Date”). At the Closing, the Company will deliver to each of the Lenders the Note and Warrant to be purchased by such Lender, against receipt by the Company of the corresponding purchase price set forth on Schedule I (the “Purchase Price”). The Company may conduct one or more additional closings on or before December 31, 2021 (each, an “Additional Closing”) to be held at such place and time as the Company and the Lenders participating in such Additional Closing may determine (each, an “Additional Closing Date”). At each Additional Closing, the Company will deliver to each of the Lenders participating in such Additional Closing the Note and Warrant to be purchased by such Lender, against receipt by the Company of the corresponding Purchase Price. Each of the Notes and Warrants will be registered in such Lender’s name in the Company’s records. Any Notes issued at an Additional Closing will begin accruing interest as of the date of such Additional Closing.
(f)Use of Proceeds. The proceeds of the sale and issuance of the Notes shall be used for general corporate purposes.
(g)Payments. The Company will make all cash payments due under the Notes in immediately available funds by 4:00 p.m. Eastern time on the date such payment is due at the address specified below each Lender’s name on Schedule I, or at such other address, or in such other manner, as the applicable Lender or other registered holder of a Note may from time to time direct in writing.
2.Representations and Warranties of the Company. The Company represents and warrants to each Lender that:
(a)Due Incorporation, Qualification, etc. The Company (i) is a corporation duly organized, validly existing and in good standing under the laws of the State of Delaware; (ii) has the power and authority to own, lease and operate its properties and carry on its business as now conducted; and (iii) is duly qualified, licensed to do business and in good standing as a foreign corporation in each jurisdiction where the failure to be so qualified or licensed could reasonably be expected to have a material adverse effect on the Company.
(b)Authority. The execution, delivery, and performance by the Company of each Transaction Document to be executed by the Company and the consummation of the transactions 
​

-3-
​

​

contemplated thereby (i) are within the power of the Company and (ii) have been duly authorized by all necessary actions on the part of the Company.
(c)Enforceability. Each Transaction Document executed, or to be executed, by the Company has been, or will be, duly executed and delivered by the Company and, assuming due execution and delivery by the other parties thereto, constitutes, or will constitute, a legal, valid, and binding obligation of the Company, enforceable against the Company in accordance with its terms, except as limited by bankruptcy, insolvency or other laws of general application relating to or affecting the enforcement of creditors’ rights generally and general principles of equity.
(d)Non-Contravention. The execution and delivery by the Company of the Transaction Documents executed by the Company and the performance and consummation of the transactions contemplated thereby do not and will not (i) violate the Company’s certificate of incorporation or bylaws or, to the Company’s knowledge, any material judgment, order, writ, decree, statute, rule or regulation applicable to the Company; (ii) violate any provision of, or result in the breach or the acceleration of, or entitle any other Person to accelerate (whether after the giving of notice or lapse of time or both), any material mortgage, indenture, agreement, instrument or contract to which the Company is a party or by which it is bound; or (iii) result in the creation or imposition of any security interest, mortgage, pledge, lien, claim, charge or other encumbrance (“Lien”) upon any property, asset or revenue of the Company or the suspension, revocation, impairment, forfeiture, or nonrenewal of any material permit, license, authorization or approval applicable to the Company, its business or operations, or any of its assets or properties. The assets of the Company are not subject to any Lien (except as permitted by Section 2(i) hereof), and the grant of a security interest pursuant to the Security Agreement will provide the Collateral Agent, for the benefit of the Lenders, with a first priority security interest on the assets of the Company. The Company covenants not to take any action, or fail to take an action, the result of which would have an adverse effect on such first priority security interest.
(e)Subsidiaries. The Company does not own or control, directly or indirectly, any interest in any corporation, partnership, limited liability company, association, or other business entity except its wholly owned subsidiary Tsu Productions, Inc.
(f)Approvals. No consent, approval, order or authorization of, or registration, declaration, or filing with, any governmental authority or other Person (including, without limitation, the shareholders of any Person) is required in connection with the execution and delivery of the Transaction Documents executed by the Company and the performance and consummation of the transactions contemplated thereby, other than such as have been obtained and remain in full force and effect and other than such qualifications or filings under applicable securities laws as may be required in connection with the transactions contemplated by this Agreement. There are no outstanding options, warrants, rights (including conversion or preemptive rights and rights of first refusal or similar rights) or agreements, orally or in writing, to purchase or acquire from the Company any Notes or Warrants.
(g)No Violation or Default. The Company is not in violation of or in default with respect to (i) its certificate of incorporation or bylaws or, to the Company’s knowledge, any material judgment, order, writ, decree, statute, rule or regulation applicable to such Person; or (ii) any material mortgage, indenture, agreement, instrument or contract to which such Person is a party or by which it is bound (nor is there any waiver in effect which, if not in effect, would result in such a violation or default).
(h)Litigation. No actions (including, without limitation, derivative actions), suits, proceedings, or investigations are pending or, to the knowledge of the Company, threatened in writing against the Company at law or in equity in any court or before any other governmental authority that (i) would (alone or in the aggregate) result in a material liability or (ii) seeks to enjoin, either directly or 
​

-4-
​

​

indirectly, the execution, delivery or performance by the Company of the Transaction Documents or the transactions contemplated thereby.
(i)Title. The Company owns and has good and marketable title in fee simple absolute to, or a valid leasehold interest in, all real properties and good title to other assets and properties as reflected in the most recent financial statements delivered to Lenders (except those assets and properties disposed of in the ordinary course of business since the date of such financial statements) and all assets and properties acquired by the Company since such date (except those disposed of in the ordinary course of business). Such assets and properties are subject to no Lien other than (i) Liens for current taxes not yet due and payable, (ii) Liens imposed by law and incurred in the ordinary course of business for obligations not past due, (iii) Liens in respect of pledges or deposits under workers’ compensation laws or similar legislation, and (iv) Liens, encumbrances and defects in title that have arisen in the ordinary course of business that do not in any case materially detract from the value of the property subject thereto or have a material adverse effect.
(j)Intellectual Property. To the Company’s knowledge, the Company owns or possesses sufficient legal rights to all patents, trademarks, service marks, trade names, copyrights, trade secrets, licenses, information, processes, and other intellectual property rights necessary for its business as now conducted and as proposed to be conducted.
(k)Financial Statements. The financial statements of the Company that have been delivered to the Lenders (i) are in accordance with the books and records of the Company and have been maintained in accordance with good business practice; (ii) have been prepared in conformity with GAAP except, with respect to the unaudited financial statements, for the absence of footnotes and subject to normal year-end adjustments; and (iii) fairly present the financial position of the Company as of the dates presented therein and the results of operations, changes in financial positions or cash flows, as the case may be, for the periods presented therein. The Company does not have any contingent obligations, liability for taxes or other outstanding obligations which are material in the aggregate, except as disclosed in the most recent financial statements furnished by the Company to Lenders prior to the date hereof.
(l)Accuracy of Information Furnished. None of the Transaction Documents and none of the other certificates, statements, or information furnished to Lenders of the Collateral Agent by or on behalf of the Company in connection with the Transaction Documents or the transactions contemplated thereby contains or will contain any untrue statement of a material fact or omits or will omit to state a material fact necessary to make the statements therein, in light of the circumstances under which they were made, not misleading. The Company does not represent or warrant that it will achieve any financial projections provided to the Lenders and represents only that such projections were prepared in good faith.
3.Representations and Warranties of Lenders. Each Lender, for that Lender alone, represents and warrants to the Company upon the acquisition of a Note and Warrant as follows:
(a)Binding Obligation. Such Lender has full legal capacity, power, and authority to execute and deliver this Agreement and to perform its obligations hereunder. This Agreement and the Transaction Documents, assuming due execution and delivery by the Company, the Collateral Agent and the other Lenders party hereto and thereto, constitute valid and binding obligations of such Lender, enforceable in accordance with their terms, except as limited by bankruptcy, insolvency or other laws of general application relating to or affecting the enforcement of creditors’ rights generally and general principles of equity.
​

-5-
​

​

(b)Securities Law Compliance. Such Lender has been advised that the Notes, the Warrants, and the underlying securities have not been registered under the Securities Act, or any state securities laws and, therefore, cannot be resold unless they are registered under the Securities Act and applicable state securities laws or unless an exemption from such registration requirements is available. Such Lender is aware that the Company is under no obligation to effect any such registration with respect to the Notes, the Warrants, or the underlying securities or to file for or comply with any exemption from registration. Such Lender has not been formed solely for the purpose of making this investment and is purchasing the Notes or Warrants to be acquired by such Lender hereunder for its own account for investment, not as a nominee or agent, and not with a view to, or for resale in connection with, the distribution thereof, and Lender has no present intention of selling, granting any participation in, or otherwise distributing the same. Such Lender has such knowledge and experience in financial and business matters that such Lender is capable of evaluating the merits and risks of such investment, is able to incur a complete loss of such investment without impairing such Lender’s financial condition and is able to bear the economic risk of such investment for an indefinite period of time. Such Lender is an accredited investor as such term is defined in Rule 501 of Regulation D under the Securities Act and shall submit to the Company such further assurances of such status as may be reasonably requested by the Company. Such Lender has furnished or made available any and all information requested by the Company or otherwise necessary to satisfy any applicable verification requirements as to accredited investor status. Any such information is true, correct, timely and complete. The residency of the Lender (or, in the case of a partnership or corporation, such entity’s principal place of business) is correctly set forth beneath such Lender’s name on Schedule I.
(c)Access to Information. Such Lender acknowledges that the Company has given such Lender access to the corporate records and accounts of the Company and to information relating to the Company, has made its officers and representatives available for interview by such Lender, and has furnished such Lender with all documents and other information required for such Lender to make an informed decision with respect to the purchase of the Notes and the Warrants.
(d)Tax Advisors. Such Lender has reviewed with its own tax advisors the U.S. federal, state, and local and non-U.S. tax consequences of this investment and the transactions contemplated by this Agreement. With respect to such matters, such Lender relies solely on any such advisors and not on any statements or representations of the Company or any of its agents, written or oral. Such Lender understands that it (and not the Company) shall be responsible for its own tax liability that may arise as a result of this investment and the transactions contemplated by this Agreement.
4.Conditions to Closing of the Lenders. Each Lender’s obligations at the Closing are subject to the fulfillment, on or prior to the Closing Date, of all of the following conditions, any of which may be waived in whole or in part by the applicable Lender:
(a)Representations and Warranties. The representations and warranties made by the Company in Section 2 shall be true and correct in all material respects on the Closing Date, except that to the extent such representations and warranties are qualified by materiality or “material adverse effect” qualifiers, they shall be true and correct on the Closing Date.
(b)Governmental Approvals and Filings. Except for any notices required or permitted to be filed after the Closing Date with certain federal and state securities commissions, the Company shall have obtained all governmental approvals required in connection with the lawful sale and issuance of the Notes and Warrants.
​

-6-
​

​

(c)Legal Requirements. At the Closing, the sale and issuance by the Company, and the purchase by the Lenders, of the Notes and Warrants shall be legally permitted by all laws and regulations to which the Lenders or the Company are subject.
(d)Proceedings and Documents. All corporate and other proceedings in connection with the transactions contemplated at the Closing and all documents and instruments incident to such transactions shall be reasonably satisfactory in substance and form to the Lenders.
(e)Transaction Documents. The Company shall have duly executed and delivered to the Lenders the following documents (the “Transaction Documents”):
(i)This Agreement;
(ii)The Secured Promissory Note issued hereunder;
(iii)The Warrant issued hereunder and
(iv)The Security Agreement, duly executed by the Company and the Collateral Agent.
5.Conditions to Additional Closings of the Lenders. The obligations of any Lender participating in an Additional Closing are subject to the fulfillment, on or prior to the applicable Additional Closing Date, of all of the following conditions, any of which may be waived in whole or in part by the applicable Lender:
(a)Representations and Warranties. The representations and warranties made by the Company in Section 2 shall be true and correct in all material respects on the Closing Date, without obligation by the Company to update such disclosures as of any Additional Closing Date.
(b)Governmental Approvals and Filings. Except for any notices required or permitted to be filed after the Additional Closing Date with certain federal and state securities commissions, the Company shall have obtained all governmental approvals required in connection with the lawful sale and issuance of the Notes and Warrants at such Additional Closing.
(c)Legal Requirements. At the Additional Closing, the sale and issuance by the Company, and the purchase by the Lenders participating in such Additional Closing, of the Notes and Warrants shall be legally permitted by all laws and regulations to which such Lenders or the Company are subject.
(d)Transaction Documents. The Company shall have duly executed and delivered to the Lenders participating in such Additional Closing each Note and each Warrant to be issued at such Additional Closing and shall have delivered to such Lenders fully executed copies, if applicable, of all documents delivered to the Lenders participating in the initial Closing.
6.Conditions to Obligations of the Company. The Company’s obligation to issue and sell the Notes and Warrants at the Closing and at each Additional Closing is subject to the fulfillment, on or prior to the Closing Date or the applicable Additional Closing Date, of the following conditions, any of which may be waived in whole or in part by the Company:
​

-7-
​

​

(a)Representations and Warranties. The representations and warranties made by the applicable Lenders in Section 3 hereof shall be true and correct when made and shall be true and correct on the Closing Date, without obligation to update such disclosures as of any Additional Closing Date.
(b)Governmental Approvals and Filings. Except for any notices required or permitted to be filed after the Closing Date or the applicable Additional Closing Date, as applicable, with certain federal and state securities commissions, the Company shall have obtained all governmental approvals required in connection with the lawful sale and issuance of the Notes and Warrants.
(c)Legal Requirements. At the Closing and at each Additional Closing, the sale and issuance by the Company, and the purchase by the applicable Lenders, of the Notes and Warrants shall be legally permitted by all laws and regulations to which such Lenders or the Company are subject.
(d)Funding. Each Lender shall have delivered to the Company the Purchase Price for its respective Notes.
7.Miscellaneous.
(a)Waivers and Amendments. Any provision of this Agreement, the Warrants, the Notes, and the Security Agreement may be amended, waived or modified only upon the written consent of the Company and the Collateral Agent; provided, however, that no such amendment, waiver or consent shall: (i) reduce the principal amount of any Note without the affected Lender’s written consent, (ii) reduce the rate of interest of any Note without the affected Lender’s written consent, or (iii) reduce the number of shares subject to the Warrant without the affected Lender’s written consent. Any amendment or waiver effected in accordance with this paragraph shall be binding upon all of the parties hereto. Notwithstanding the foregoing, this Agreement may be amended to add a party as a Lender hereunder in connection with Additional Closings without the consent of any other Lender, by delivery to the Company of a counterparty signature page to this Agreement, together with a supplement to Schedule I. Such amendment shall take effect at the Additional Closing and such party shall thereafter be deemed a “Lender” for all purposes hereunder and Schedule I shall be updated to reflect the addition of such Lender.
(b)Governing Law. This Agreement and all actions arising out of or in connection with this Agreement shall be governed by and construed in accordance with the laws of the State of New York, without regard to the conflicts of law provisions of the State of New York or of any other state.
(c)Jurisdiction and Venue. Each of the parties irrevocably consents to the exclusive jurisdiction of, and venue in, the state courts in New York County in the State of New York (or in the event of exclusive federal jurisdiction, the courts of the Eastern District of New York), in connection with any matter based upon or arising out of this Agreement or the matters contemplated herein and agrees that process may be served upon them in any manner authorized by the laws of the State of New York for such persons.
(d)Survival. The representations, warranties, covenants, and agreements made herein shall survive the execution and delivery of this Agreement.
(e)Successors and Assigns. Subject to the restrictions on transfer described in Section 7(f), the rights and obligations of the Company and the Lenders shall be binding upon and benefit the successors, assigns, heirs, administrators and transferees of the parties.
​

-8-
​

​

(f)Registration, Transfer and Replacement of the Notes. The Notes issuable under this Agreement shall be registered notes. The Company will keep, at its principal executive office, books for the registration and registration of transfer of the Notes. Prior to presentation of any Note for registration of transfer, the Company shall treat the Person in whose name such Note is registered as the owner and holder of such Note for all purposes whatsoever, whether or not such Note shall be overdue, and the Company shall not be affected by notice to the contrary. Subject to any restrictions on or conditions to transfer set forth in any Note, the holder of any Note, at its option, may in person or by duly authorized attorney surrender the same for exchange at the Company’s chief executive office, and promptly thereafter and at the Company’s expense, except as provided below, receive in exchange therefor one or more new Note(s), each in the principal requested by such holder, dated the date to which interest shall have been paid on the Note so surrendered or, if no interest shall have yet been so paid, dated the date of the Note so surrendered and registered in the name of such Person or Persons as shall have been designated in writing by such holder or its attorney for the same principal amount as the then unpaid principal amount of the Note so surrendered. Upon receipt by the Company of evidence reasonably satisfactory to it of the ownership of and the loss, theft, destruction or mutilation of any Note and (a) in the case of loss, theft or destruction, of indemnity reasonably satisfactory to it; or (b) in the case of mutilation, upon surrender thereof, the Company, at its expense, will execute and deliver in lieu thereof a new Note executed in the same manner as the Note being replaced, in the same principal amount as the unpaid principal amount of such Note and dated the date to which interest shall have been paid on such Note or, if no interest shall have yet been so paid, dated the date of such Note.
(g)Fees and Expenses. Promptly following the Closing Date, the Company shall pay the reasonable fees and expenses of Lenders’ counsel in an amount not to exceed $10,000 in the aggregate.
(h)Entire Agreement. This Agreement together with the other Transaction Documents and (with respect to particular investors) any management rights letters entered into in connection with the Transaction Documents, constitute and contain the entire agreement among the Company and Lenders and supersede any and all prior agreements, negotiations, correspondence, understandings, and communications among the parties, whether written or oral, respecting the subject matter hereof.
(i)Notices. All notices and other communications required or permitted hereunder shall be in writing and shall be mailed by registered or certified mail, postage prepaid, sent by facsimile or electronic mail (if to a Lender or any other holder of Company securities) or otherwise delivered by hand, messenger or courier service addressed:
(i)if to a Lender, to the Lender’s address, facsimile number or electronic mail address as shown on Schedule I, as may be updated in accordance with the provisions hereof, with a copy (which shall not constitute notice) to the Collateral Agent;
(ii)if to any other holder of any Notes, to such address, facsimile number or electronic mail address as shown in the Company’s records, or, until any such holder so furnishes an address, facsimile number, or electronic mail address to the Company, then to the address, facsimile number, or electronic mail address of the last holder of such Notes for which the Company has contact information in its records; or
(iii)if to the Company, to the attention of the Chief Financial Officer of the Company at 75 North Water Street, Norwalk, CT 06854 or at such other current address as the Company shall have furnished to the Lenders, with a copy (which shall not constitute notice) to the General Counsel of the Company at 75 North Water Street, Norwalk, CT 06854.
​

-9-
​

​

Each such notice or other communication shall for all purposes of this Agreement be treated as effective or having been given (i) if delivered by hand, messenger or courier service, when delivered (or if sent via a nationally-recognized overnight courier service, freight prepaid, specifying next-business-day delivery, one business day after deposit with the courier), or (ii) if sent via mail, at the earlier of its receipt or five days after the same has been deposited in a regularly-maintained receptacle for the deposit of the United States mail, addressed and mailed as aforesaid, or (iii) if sent via facsimile, upon confirmation of facsimile transfer or, if sent via electronic mail, upon confirmation of delivery when directed to the relevant electronic mail address, if sent during normal business hours of the recipient, or if not sent during normal business hours of the recipient, then on the recipient’s next business day.
(j)Conflicts.  In the event of any conflict or inconsistency between the provisions of this Agreement and provisions of any other Transaction Document, the provisions of this Agreement shall control.
(k)Separability of Agreements; Severability of this Agreement. The Company’s agreement with each of the Lenders is a separate agreement and the sale of the Notes to each of the Lenders is a separate sale. Unless otherwise expressly provided herein, the rights of each Lender hereunder are several rights, not rights jointly held with any of the other Lenders. Any invalidity, illegality, or limitation on the enforceability of the Agreement or any part thereof, by any Lender whether arising by reason of the law of the respective Lender’s domicile or otherwise, shall in no way affect or impair the validity, legality, or enforceability of this Agreement with respect to other Lenders. If any provision of this Agreement shall be judicially determined to be invalid, illegal, or unenforceable, the validity, legality and enforceability of the remaining provisions shall not in any way be affected or impaired thereby.
(l)Counterparts. This Agreement may be executed in one or more counterparts, each of which will be deemed an original, but all of which together will constitute one and the same agreement. Copies of signed signature pages delivered by facsimile or in electronic (i.e., “pdf” or “tif”) format will be deemed binding originals.
(Signature page follows)
​
​

-10-
​

​

The parties are signing this Note and Warrant Purchase Agreement as of the date stated in the introductory clause.
	​

	

	

	​
	TSU INC. (D/B/A DISPLAY)

	​
	a Delaware corporation

	​
	​

	​
	​

	​
	By:
	/s/ Scot Weisberg

	​
	Name:
	Scot Weisberg

	​
	Title:
	Chief Financial Officer

​
​

(Signature page for Note and Warrant Purchase Agreement)

​

The parties are signing this Note and Warrant Purchase Agreement as of the date stated in the introductory clause.
	​

	

	

	​
	BLACK, INC.

	​
	as Collateral Agent

	​
	​

	​
	​

	​
	By:
	/s/ Larry Krauss

	​
	Name:
	Larry Krauss

	​
	Title:
	

​

(Signature page for Note and Warrant Purchase Agreement)

​

The parties are signing this Note and Warrant Purchase Agreement as of the date stated in the introductory clause.
	​
	    
	LENDER

	​
	​
	​

	​
	​
	​

	​
	​
	Black, Inc.

	​
	​
	(Print investor name)

	​
	​
	​

	​
	​
	​

	​
	​
	/s/ Larry Krauss

	​
	​
	(Signature)

	​
	​
	​

	​
	​
	​

	​
	​
	Larry Krauss

	​
	​
	(Print name of signatory, if signing for an entity)

	​
	​
	​

	​
	​
	​

	​
	​
	​

	​
	​
	(Print title of signatory, if signing for an entity)

	​
	​
	​

	​
	​
	​

	​
	​
	​

	​
	​
	(Date)

​

(Signature page for Note and Warrant Purchase Agreement)

​

The parties are signing this Note and Warrant Purchase Agreement as of the date stated in the introductory clause.
	​

	​

	​

	​
	    
	LENDER

	​
	​
	​

	​
	​
	​

	​
	​
	Team AJ, LLC

	​
	​
	(Print investor name)

	​
	​
	​

	​
	​
	​

	​
	​
	/s/ John Acunto

	​
	​
	(Signature)

	​
	​
	​

	​
	​
	​

	​
	​
	John Acunto

	​
	​
	(Print name of signatory, if signing for an entity)

	​
	​
	​

	​
	​
	​

	​
	​
	​

	​
	​
	(Print title of signatory, if signing for an entity)

	​
	​
	​

	​
	​
	​

	​
	​
	​

	​
	​
	(Date)

​

​

​

The parties are signing this Note and Warrant Purchase Agreement as of the date stated in the introductory clause.
	​

	​

	​

	​
	    
	LENDER

	​
	​
	​

	​
	​
	​

	​
	​
	Mark Norbom

	​
	​
	(Print investor name)

	​
	​
	​

	​
	​
	​

	​
	​
	/s/ Mark Norbom

	​
	​
	(Signature)

	​
	​
	​

	​
	​
	​

	​
	​
	Mark Norbom

	​
	​
	(Print name of signatory, if signing for an entity)

	​
	​
	​

	​
	​
	​

	​
	​
	NA

	​
	​
	(Print title of signatory, if signing for an entity)

	​
	​
	​

	​
	​
	​

	​
	​
	​

	​
	​
	(Date)

​

​

​

SCHEDULE I
SCHEDULE OF LENDERS
	​
​
​
​
​
​
​

	​

	

	​

	Name
	Address
	Principal Amount
	Warrant Exercise
Price1

	Black, Inc.
	100 Shephard Avenue East, Suite 502, Toronto, Ontario, Canada M2N 6N5
Email: LKrauss@terracap.ca
Copy to: tbrown@terracap.ca
	$2,000,000.00
	$1.86

	John Acunto
	635 Springer Road, Fairfield, CT 06824
Email: john.teamaj@gmail.com
Copy to: j@displaysocial.com
	$2,000,000.00
	$1.86

	Mark Norbom
	6 Pan Handle Lane, Westport, CT 06880
Email: Norbommark@gmail.com
	$250,000.00
	$1.86

	​
	​
	​
	​

	​
	​
	​
	​

	​
	​
	​
	​

	​
	​
	​
	​

	​
	​
	​
	​

	​
	​
	​
	​

	​
	​
	​
	​

	​
	​
	​
	​

	​
	​
	​
	​

	​
	​
	​
	​

	Total
	​
	$4,250,000
	​

​

1 To be calculated based on a $250 million equity valuation and the actual number of outstanding Common Shares of the Company on the date this Agreement is signed.
​

​

​

FORM OF NOTE
THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR UNDER THE SECURITIES LAWS OF CERTAIN STATES. THESE SECURITIES MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED EXCEPT AS PERMITTED UNDER THE SECURITIES ACT AND APPLICABLE STATE SECURITIES LAWS PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT OR AN EXEMPTION THEREFROM. THE ISSUER OF THESE SECURITIES MAY REQUIRE AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE ISSUER THAT SUCH OFFER, SALE OR TRANSFER, PLEDGE OR HYPOTHECATION OTHERWISE COMPLIES WITH THE SECURTIES ACT AND ANY APPLICABLE STATE SECURITIES LAWS.
TSU INC. (D/B/A DISPLAY)
SECURED PROMISSORY NOTE
$ _____________________ __, 2021
1.FOR VALUE RECEIVED, tsu Inc. (d/b/a display), a Delaware corporation (the “Company”), promises to pay to _____________, or its registered assigns (“Lender”), in lawful money of the United States of America, the principal sum of ________________ Dollars ($ _________), or such lesser amount as shall equal the outstanding principal amount hereof, together with simple interest from the date of this Secured Promissory Note (this “Note”) on the unpaid principal balance at a rate equal to 12.5% per annum, computed on the basis of the actual number of days elapsed and a year of 365 days. All unpaid principal, together with any then unpaid and accrued interest and other amounts payable hereunder, shall be due and payable on the earlier of (i) twelve (12) months from the date hereof (the “Maturity Date”), or (ii) when, upon the occurrence and during the continuance of an Event of Default, such amounts are declared due and payable by Lender or made automatically due and payable, in each case, in accordance with the terms hereof.
This Note is one of a series of Secured Promissory Notes issued pursuant to a Note Purchase Agreement, dated as of ____ ___, 2021 (as amended, modified, or supplemented, the “Note Purchase Agreement”), by and among the Company and the Lenders (as defined in the Note Purchase Agreement) party thereto and is entitled to the benefits thereof.  Capitalized terms used but not otherwise defined herein shall have the meanings assigned to such terms in the Note Purchase Agreement.  Lender will be deemed, by its acceptance hereof, to have agreed to the provisions and to have made the representations and warranties set forth in the Note Purchase Agreement.
The following is a statement of the rights of Lender and the conditions to which this Note is subject, and to which Lender, by the acceptance of this Note, agrees:
2.Payments.
(a)Interest. Interest shall accrue from and including the date of this Note to and including the date on which this Note is paid in full. Accrued interest on this Note shall be payable in arrears quarterly on March 30, June 30, September 30 and December 31 of each year, with the first installment of accrued interest being due and payable on November 1, 2021 (if any such date is not a business day, on the next succeeding business day following such date).
​

​

​

(b)Funding Fee. An amount equal to one percent (1%) of the principal amount of this Note payable at maturity or earlier pre-payment.
(c)Voluntary Prepayment. The principal and accrued interest on this Note may be prepaid without penalty at any time.
3.Mandatory Prepayment. The Company shall be required to prepay all principal and accrued interest on this Note, plus a repayment premium equal to the difference between 12.5% of the outstanding principal amount of this Note and the amount of interest actually accrued on this Note through the date of repayment, immediately prior to the consummation of any of the following events: (a) any consolidation or merger of the Company with or into any other corporation or other entity or person, or any other corporate reorganization, other than any such consolidation, merger or reorganization in which the stockholders of the Company immediately prior to such consolidation, merger or reorganization continue to hold at least a majority of the voting power of the surviving entity in substantially the same proportions (or, if the surviving entity is a wholly owned subsidiary, its parent) immediately after such consolidation, merger or reorganization; (b) any transaction or series of related transactions to which the Company is a party in which in excess of 50% of the Company’s voting power is transferred; and (c) the sale of all, or substantially all, the Company’s assets.
4.Events of Default. The occurrence of any of the following shall constitute an “Event of Default” under this Note and the other Notes, the Warrants, the Security Agreement, and the Purchase Agreement (the “Transaction Documents”):
(a)Failure to Pay. The Company shall fail to pay (i) when due any principal payment on the due date hereunder or (ii) any interest payment or other payment required under the terms of this Note or any other Transaction Document on the date due and such payment shall not have been made within five (5) business days of the Company’s receipt of written notice to the Company of such failure to pay;
(b)Breaches of Covenants. The Company shall fail to observe or perform any other covenant, obligation, condition, or agreement contained in this Note or the other Transaction Documents (other than those specified in Section 4(a)) and such failure shall continue for ten (10) business days after the Company’s receipt of written notice to the Company of such failure;
(c)Representations and Warranties. Any representation, warranty, certificate, or other statement (financial or otherwise) made or furnished by or on behalf of the Company to Lender in writing in connection with this Note or any of the other Transaction Documents, or as an inducement to Lender to enter into this Note and the other Transaction Documents, shall be false, incorrect, incomplete, or misleading in any material respect when made or furnished;
(d)Other Payment Obligations. Defaults shall exist under (i) any agreements of the Company with any third party or parties which consists of the failure to pay any indebtedness for borrowed money at maturity or which results in a right by such third party or parties, whether or not exercised, to accelerate the maturity of such indebtedness for borrowed money of the Company, in each case, in an aggregate amount in excess of One Million Dollars ($1,000,000.00) or (ii) any other Note;
(e)Voluntary Bankruptcy or Insolvency Proceedings. The Company (i) shall apply for or consent to the appointment of a receiver, trustee, liquidator, or custodian of itself or of all or a substantial part of its property, (ii) is unable to pay its debts generally as they mature, (iii) make a general assignment for the benefit of its or any of its creditors, (iv) shall be dissolved or liquidated, (v) shall commence a voluntary case or other proceeding seeking liquidation, reorganization, or other relief with respect to itself or its debts under any bankruptcy, insolvency or other similar law now or hereafter in effect or consent to any such relief or to the appointment of or taking possession of its property by any official in an involuntary case or other proceeding commenced against it, (vi) is unable to pay payables as they come due in the ordinary course of business, or (vi) take any action for the purpose of effecting any of the foregoing;
​

​

​

(f)Involuntary Bankruptcy or Insolvency Proceedings. Proceedings for the appointment of a receiver, trustee, liquidator or custodian of the Company, or of all or a substantial part of the property thereof, or an involuntary case or other proceedings seeking liquidation, reorganization or other relief with respect to the Company or any of its subsidiaries, if any, or the debts thereof under any bankruptcy, insolvency or other similar law now or hereafter in effect shall be commenced and an order for relief entered or such proceeding shall not be dismissed or discharged within 60 days of commencement; or
(g)Judgments. A final judgment or order for the payment of money in excess of One Million Dollars ($1,000,000.00) (exclusive of amounts covered by insurance) shall be rendered against the Company and the same shall remain undischarged for a period of 45 days during which execution shall not be effectively stayed, or any judgment, writ, assessment, warrant of attachment, or execution or similar process shall be issued or levied against a substantial part of the property of the Company or any of its subsidiaries, if any and such judgment, writ, or similar process shall not be released, stayed, vacated or otherwise dismissed within 45 days after issue or levy.
5.Rights of Lender upon Default. Upon the occurrence of any Event of Default (other than an Event of Default described in Section 4(e) or 4(f)) and at any time thereafter during the continuance of such Event of Default, Lender may, with the written consent of Black, Inc. as lead lender (the “Lead Lender”), by written notice to the Company, declare all outstanding obligations payable by the Company hereunder to be immediately due and payable without presentment, demand, protest or any other notice of any kind, all of which are hereby expressly waived, anything contained herein or in the other Transaction Documents to the contrary notwithstanding. Upon the occurrence of any Event of Default described in Section 4(e) or 4(f), immediately and without notice, all outstanding obligations payable by the Company hereunder shall automatically become immediately due and payable, without presentment, demand, protest or any other notice of any kind, all of which are hereby expressly waived, anything contained herein or in the other Transaction Documents to the contrary notwithstanding. In addition to the foregoing remedies, upon the occurrence and during the continuance of any Event of Default, Lender may, with the written consent of the Lead Lender, exercise any other right, power or remedy granted to it by the Transaction Documents or otherwise permitted to it by law, either by suit in equity or by action at law, or both.
6.Security. This Note and all obligations of the Company hereunder are secured by a first priority security interest on all assets of the Company including intellectual property (the “Collateral”) as provided for in the Security Agreement, dated as of the date hereof (as amended, restated, modified, or supplemented from time to time, the “Security Agreement”), entered into by and between the Company and the Collateral Agent (as defined in the Security Agreement).
7.Warrants.
(a)The Lender will receive warrants to acquire that number of common shares of the Company, par value $0.001 (“Common Shares”) having a dollar value equal to  fifteen percent (15%) of the principal amount of this Note (the “Warrants”) as set forth in the Warrant to Purchase Common Stock (as amended, restated, modified, or supplemented from time to time, the “Warrant Agreement”), calculated using the following formula:   Principal amount of this Note x 15%/$250,000,000 x the number of Common Shares outstanding on the day immediately preceding the date of this Note.
(b)The Warrants will be issued to the Lender concurrently with the execution of this Note, and (i) shall be exercisable until December 31, 2026, (ii) have an exercise price of $1.86 per Warrant share and (iii) have such other terms as provided for in the Warrant Agreement.
​

​

​

8.Miscellaneous.
(a)Successors and Assigns; Transfer of this Note; No Transfers to Bad Actors; Notice of Bad Actor Status.
(i)Subject to the restrictions on transfer described in this Section 8(a), the rights and obligations of the Company and Lender shall be binding upon and benefit the successors, assigns, heirs, administrators, and transferees of the parties.
(ii)With respect to any offer, sale, or other disposition of this Note, Lender will give written notice to the Company prior thereto, describing briefly the manner thereof, together with a written opinion of Lender’s counsel, or other evidence if reasonably satisfactory to the Company, to the effect that such offer, sale or other distribution may be effected without registration or qualification (under any federal or state law then in effect). Upon receiving such written notice and reasonably satisfactory opinion, if so requested, or other evidence, the Company, as promptly as practicable, shall notify Lender that Lender may sell or otherwise dispose of this Note, all in accordance with the terms of the notice delivered to the Company. If a determination has been made pursuant to this Section 8(a) that the opinion of counsel for Lender, or other evidence, is not reasonably satisfactory to the Company, the Company shall so notify Lender promptly after such determination has been made. Each Note thus transferred shall bear a legend as to the applicable restrictions on transferability in order to ensure compliance with the Securities Act, unless in the opinion of counsel for the Company such legend is not required in order to ensure compliance with the Securities Act. The Company may issue stop transfer instructions to its transfer agent in connection with such restrictions.
(iii)Subject to Section 8(a)(ii), transfers of this Note shall be registered upon registration books maintained for such purpose by or on behalf of the Company as provided in the Note Purchase Agreement. Prior to presentation of this Note for registration of transfer, the Company shall treat the registered holder hereof as the owner and holder of this Note for the purpose of receiving all payments of principal and interest hereon and for all other purposes whatsoever, whether or not this Note shall be overdue and the Company shall not be affected by notice to the contrary.
(iv)Neither this Note nor any of the rights, interests or obligations hereunder may be assigned, by operation of law or otherwise, in whole or in part, by the Company without the prior written consent of the Lead Lender.
(v)Lender agrees not to sell, assign, transfer, pledge or otherwise dispose of any securities of the Company, or any beneficial interest therein, to any person (other than the Company) unless and until the proposed transferee confirms to the reasonable satisfaction of the Company that neither the proposed transferee nor any of its directors, executive officers, other officers that may serve as a director or officer of any company in which it invests, general partners or managing members nor any person that would be deemed a beneficial owner of those securities (in accordance with Rule 506(d) under the Securities Act) is subject to any of the “bad actor” disqualifications described in Rule 506(d)(1)(i) through (viii) under the Securities Act, except as set forth in Rule 506(d)(2)(ii) or (iii) or (d)(3) under the Securities Act and disclosed, reasonably in advance of the transfer, in writing in reasonable detail to the Company. Lender will promptly notify the Company in writing if Lender or, to Lender’s knowledge, any person specified in Rule 506(d)(1) under the Securities Act becomes subject to any of the “bad actor” disqualifications described in Rule 506(d)(1)(i) through (viii) under the Securities Act.
(b)Waiver and Amendment. Any provision of this Note may be amended, waived, or modified upon the written consent of the Company and the Lead Lender; provided, however, that no such amendment, waiver or consent shall: (i) reduce the principal amount of this Note without Lender’s written consent, or (ii) reduce the rate of interest of this Note without Lender’s written consent.
​

​

​

(c)Notices. All notices and other communications required or permitted hereunder shall be in writing and shall be mailed by registered or certified mail, postage prepaid, sent by facsimile or electronic mail (if to Lender) or otherwise delivered by hand, messenger or courier service addressed:
(i)if to Lender, to Lender’s address, facsimile number or electronic mail address as shown on Schedule I to the Note Purchase Agreement, as may be updated in accordance with the provisions hereof, or, until such holder so furnishes an address, facsimile number, or electronic mail address to the Company, then to the address, facsimile number, or electronic mail address of the last holder of this Note for which the Company has contact information in its records; or
(ii)if to the Company, to the attention of the Chief Financial Officer of the Company at 75 North Water Street, Norwalk, CT 06880 or at such other current address as the Company shall have furnished to Lender, with a copy (which shall not constitute notice) to General Counsel of the Company the same address.
Each such notice or other communication shall for all purposes of this Note be treated as effective or having been given (i) if delivered by hand, messenger or courier service, when delivered (or if sent via a nationally-recognized overnight courier service, freight prepaid, specifying next-business-day delivery, one business day after deposit with the courier), or (ii) if sent via mail, at the earlier of its receipt or five days after the same has been deposited in a regularly-maintained receptacle for the deposit of the United States mail, addressed and mailed as aforesaid, or (iii) if sent via facsimile, upon confirmation of facsimile transfer or, if sent via electronic mail, upon confirmation of delivery when directed to the relevant electronic mail address, if sent during normal business hours of the recipient, or if not sent during normal business hours of the recipient, then on the recipient’s next business day. In the event of any conflict between the Company’s books and records and this Note or any notice delivered hereunder, the Company’s books and records will control absent fraud or error.
(d)Pari Passu Notes. Lender acknowledges and agrees that the payment of all or any portion of the outstanding principal amount of this Note and all interest hereon shall be pari passu in right of payment and in all other respects to any other Notes issued as part of this series of Notes pursuant to the Note Purchase Agreement.
(e)Payment. Payment shall be made in lawful tender of the United States.
(f)Usury. In the event any interest is paid on this Note which is deemed to be in excess of the then legal maximum rate, then that portion of the interest payment representing an amount in excess of the then legal maximum rate shall be deemed a payment of principal and applied against the principal of this Note.
(g)Waivers. The Company hereby waives notice of default, presentment or demand for payment, protest or notice of nonpayment or dishonor and all other notices or demands relative to this instrument.
(h)Governing Law. This Note and all actions arising out of or in connection with this Note shall be governed by and construed in accordance with the laws of the State of New York without regard to the conflicts of law provisions of the State of New York, or of any other state.
(i)Jurisdiction and Venue. Each of Lender and the Company irrevocably consents to the exclusive jurisdiction of, and venue in, the state courts in New York County in the State of New York (or in the event of exclusive federal jurisdiction, the courts of the Eastern District of New York), in connection with any matter based upon or arising out of this Note or the matters contemplated herein, and agrees that process may be served upon them in any manner authorized by the laws of the State of New York for such persons.
The Company has caused this Note to be issued as of the date first written above.
tsu Inc. (d/b/a display)
​

​

​

	​
​
​
​
​

	​

	​

	​
	a Delaware corporation

	​
	​
	​

	​
	By:
	​

	​
	Name:
	​

	​
	Title:
	​

​

​

​

Exhibit B
FORM OF SECURITY AGREEMENT
SECURITY AGREEMENT
This SECURITY AGREEMENT, dated as of June ___, 2021 (as amended, supplemented, or otherwise modified from time to time in accordance with the provisions hereof, this “Agreement”), made by and among tsu Inc. (d/b/a display), a Delaware corporation (the “Grantor”), in favor of Black, Inc., a Ontario corporation, as collateral agent (the “Collateral Agent”) for the Lenders party to that certain Note and Warrant Purchase Agreement dated as of the date hereof (the “Purchase Agreement”), pursuant to which the Grantor has agreed to issue up to $ ________ in principal amount of Secured Promissory Notes (collectively, the “Notes”), and other holders of the Notes, (collectively, the “Lenders” and each, a “Lender”).
WHEREAS, the Grantor, the Lenders party thereto and the Collateral Agent have entered into that certain Note and Warrant Purchase Agreement dated as of the date hereof (the “Purchase Agreement”), pursuant to which the Grantor has agreed to issue up to $ ________ in principal amount of Secured Promissory Notes (collectively, the “Notes”). Capitalized terms used but not otherwise defined herein shall have the meanings assigned to such terms in the Purchase Agreement;
WHEREAS, to induce the Lenders to make the financial accommodations provided to the Grantor pursuant to each Note, the Grantor has agreed to secure the performance of the Grantor’s obligations under the Notes and the Purchase Agreement, and the Company desires to pledge, grant, transfer and assign to the Collateral Agent for the benefit of the Lenders a security interest in the Collateral (as defined below) to secure the Secured Obligations (as defined below), as provided herein.
NOW, THEREFORE, in consideration of the mutual covenants, terms, and conditions set forth herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows:
1.Definitions.
(a)Unless otherwise specified herein, all references to Sections and Schedules herein are to Sections and Schedules of this Agreement.
(b)Unless otherwise defined herein, terms used herein that are defined in the UCC shall have the meanings assigned to them in the UCC. However, if a term is defined in Article 9 of the UCC differently than in another Article of the UCC, the term has the meaning specified in Article 9.
(c)For purposes of this Agreement, the following terms shall have the following meanings:
“Collateral” has the meaning set forth in Section 2.
“Event of Default” has the meaning set forth in the Note.
“Proceeds” means “proceeds” as such term is defined in section 9-102 of the UCC and, in any event, shall include, without limitation, all dividends or other income from the Collateral, collections thereon, or distributions with respect thereto.
“Secured Obligations” has the meaning set forth in Section 2.(a).
“UCC” means the Uniform Commercial Code as in effect from time to time in the [State of California] or, when the laws of any other state govern the method or manner of the perfection or
​

​

​

enforcement of any security interest in any of the Collateral, the Uniform Commercial Code as in effect from time to time in such state.
2.Grant of Security Interest. The Grantor hereby pledges and grants to the Collateral Agent for the benefit of the Lenders, and hereby creates a continuing lien and security interest in favor of the Collateral agent for the benefit of the Lenders in and to all of its right, title, and interest in and to the following, wherever located, whether now existing or hereafter from time to time arising or acquired (collectively, the “Collateral”):
(a)All “accounts,” as that term is defined in Article 9 of the UCC, including, without limitation, every right to payment for goods or other property of any kind sold or leased or for services rendered or for any other transaction, whether or not the right to payment has been earned by performance, and including, without limitation, every account receivable, all purchase orders, all interest in goods the sale or lease of which gives rise to the right to payment (including returned or repossessed goods and unpaid seller’s rights), and the rights pertaining to such goods, including the right to stoppage in transit, every right to payment under any contract, and every lien, guaranty, or security interest that secures a right to payment for any of the foregoing (“Accounts”);
(b)All code, code repositories, software and applications operating and comprising the display social media app, and all property rights embedded in the software, if any, such as inventions, discoveries, improvements, ideas, trade secrets, know-how or confidential information;
(c)All patents, trademarks, copyrights, domain names, web addresses and other intellectual property.
(d)All chattel paper, consisting of a writing or writings evidencing both a monetary obligation and a security interest in or lease of goods, together with any guarantees, letters of credit, and other security therefore (“Chattel Paper”);
(e)All “deposit accounts,” as defined in the UCC (“Deposit Accounts”);
(f)All “inventory” of whatever kind, as that term is used in the UCC, including, without limitation, all goods held by the Grantor for sale or lease, goods furnished or to be furnished under a contract for service, and supplies, packaging, raw materials, goods in transit, work-in-process, and materials used or consumed or to be used or consumed in the Grantor’s business, or in the processing, packaging, or shipping of same, all finished goods, and all property, the sale or lease of which has given rise to Accounts, Chattel Paper, or Instruments, and that has been returned to the Grantor or repossessed by the Grantor or stopped in transit, and all warranties and related claims, credits, setoffs, and other rights of recovery with respect to any of the foregoing (“Inventory”);
(g)All “equipment,” as that term is used in the UCC, including, without limitation, all equipment, machinery, and other property held for use in or purchased for the Grantor’s business, together with all increases, parts, fittings, accessories, repair equipment, and special tools now or later affixed to, or used in connection with, that property, all transferable rights of the Grantor to the licenses and warranties (express and implied) received from the sellers and manufacturers of the foregoing property, all related claims, credits, setoffs, and other rights of recovery (in each case, excluding any equipment that is subject to a lien or security interest by a third party as of the date of this Agreement) (“Equipment”);
(h)All “instruments,” including, without limitation, every instrument of any kind, as that term is used in the UCC, and includes every promissory note, negotiable instrument, certificated security, or other writing that evidences a right to payment of money, that is not a lease or security agreement, and that is transferred in the ordinary course of business by delivery with any necessary assignment or indorsement (“Instruments”);
​

9
​

​

(i)“Investment property,” as that term is defined in the UCC (“Investment Property”);
(j)All documents, including, without limitation, any paper that is treated in the regular course of business as adequate evidence that the person in possession of the paper is entitled to receive, hold, and dispose of the goods the paper covers, including warehouse receipts, bills of lading, certificates of title, and applications for certificates of title;
(k)All “general intangibles” of any kind, as that term is used in the UCC, and includes without limitation all intangible personal property other than Accounts, Documents, Instruments and Chattel Paper, and includes, without limitation, money, contract rights, corporate or other business records, deposit accounts, inventions, designs, formulas, patents, service marks, trademarks, trade names, trade secrets, engineering drawings, goodwill, rights to prepaid expenses, registrations, franchises, copyrights, licenses, customer lists, computer programs and other software, source code, tax refund claims, royalty, licensing and product rights, all claims under guarantees, security interests or other security held by or granted to the Grantor to secure payment of any of the Accounts by an Account Debtor, all indemnification rights, and rights to retrieval from third parties of electronically processed and recorded data pertaining to any Collateral, things in action, items, checks, drafts, and orders in transit to or from the Grantor, credits or deposits of the Grantor (whether general or special) that are held by the Collateral Agent (“General Intangibles”);
(l)“Supporting obligations,” as that term is defined in the UCC (“Supporting Obligations”); and
(m)To the extent not listed above in clauses (a)-(l), (i) all other assets of the Company, whether tangible or intangible, and (ii) proceeds and products of the foregoing.
Notwithstanding anything to the contrary in the foregoing, the term “Collateral” shall not include any equipment that is subject to a lien or security interest by a third party as of the date of this Agreement.
3.Secured Obligations. The Collateral secures the due and prompt payment and performance of:
(a)the obligations of the Grantor from time to time arising under the Note, this Agreement, or otherwise with respect to the due and prompt payment of (i) the principal of and premium, if any, and interest on the Note (including interest accruing during the pendency of any bankruptcy, insolvency, receivership, or other similar proceeding, regardless of whether allowed or allowable in such proceeding), when and as due, whether at maturity, by acceleration, upon one or more dates set for prepayment, or otherwise and (ii) all other monetary obligations, including fees, costs, attorneys’ fees and disbursements, reimbursement obligations, contract causes of action, expenses, and indemnities, whether primary, secondary, direct or indirect, absolute or contingent, due or to become due, now existing or hereafter arising, fixed or otherwise (including monetary obligations incurred during the pendency of any bankruptcy, insolvency, receivership, or other similar proceeding, regardless of whether allowed or allowable in such proceeding), of the Grantor under or in respect of the Note and this Agreement; and
(b)all other covenants, duties, debts, obligations, and liabilities of any kind of the Grantor under or in respect of the Note, this Agreement, or any other document made, delivered, or given in connection with any of the foregoing, in each case whether evidenced by a note or other writing, whether allowed in any bankruptcy, insolvency, receivership, or other similar proceeding, whether arising from an extension of credit, issuance of a letter of credit, acceptance, loan, guaranty, indemnification, or otherwise, and whether primary, secondary, direct or indirect, absolute or contingent, due or to become due, now existing or hereafter arising, fixed or otherwise (all such obligations, covenants, duties, debts, liabilities, sums, and expenses set forth in this Section 2 being herein collectively called the “Secured Obligations”).
​

10
​

​

4.Perfection of Security Interest and Further Assurances.
(a)The Grantor shall, from time to time, as may be required by the Collateral Agent with respect to all Collateral, take all actions as may be requested by the Collateral Agent to perfect the security interest of the Collateral Agent, for the benefit of the Lenders, in the Collateral, at the sole cost and expense of the Grantor.
(b)The Grantor hereby irrevocably authorizes the Collateral Agent at any time and from time to time to file in any relevant jurisdiction any financing statements and amendments thereto that contain the information required by Article 9 of the UCC of each applicable jurisdiction for the filing of any financing statement or amendment relating to the Collateral, including any financing or continuation statements or other documents for the purpose of perfecting, confirming, continuing, enforcing, or protecting the security interest granted by the Grantor hereunder, without the signature of the Grantor where permitted by law, including the filing of a financing statement describing the Collateral as all assets now owned or hereafter acquired by the Grantor, or words of similar effect. The Grantor agrees to provide all information required by the Collateral Agent pursuant to this Section promptly to the Collateral Agent request.
(c)The Grantor agrees that at any time and from time to time, at the expense of the Grantor, the Grantor will promptly execute and deliver all further instruments and documents, obtain such agreements from third parties, and take all further action, that may be necessary or desirable, or that the Collateral Agent may reasonably request, in order to create and/or maintain the validity, perfection, or priority of and protect any security interest granted or purported to be granted hereby or to enable the Collateral Agent, for the benefit of the Lenders, to exercise and enforce its rights and remedies hereunder or under any other agreement with respect to any Collateral.
5.Representations and Warranties. The Grantor represents and warrants as follows:
(a)At the time the Collateral becomes subject to the lien and security interest created by this Agreement, the Grantor will be the sole, direct, legal, and beneficial owner thereof, free and clear of any lien, security interest, encumbrance, claim, option, or right of others except for the security interest created by this Agreement and other liens permitted by the Notes.
(b)The pledge of the Collateral pursuant to this Agreement creates a valid and perfected first priority security interest in the Collateral, securing the payment and performance when due of the Secured Obligations.
(c)It has power and authority to pledge the Collateral pursuant to this Agreement.
(d)Each of this Agreement and the Note has been duly authorized, executed, and delivered by the Grantor and constitutes a legal, valid, and binding obligation of the Grantor enforceable in accordance with its terms, except as limited by bankruptcy, insolvency or other laws of general application relating to or affecting the enforcement of creditors’ rights generally and general principles of equity.
(e)No authorization, approval, or other action by, and no notice to or filing with, any governmental authority or regulatory body is required for the pledge by the Grantor of the Collateral pursuant to this Agreement or for the execution and delivery of the Note and this Agreement by the Grantor or the performance by the Grantor of its obligations thereunder.
(f)The execution and delivery of the Note and this Agreement by the Grantor and the performance by the Grantor of its obligations thereunder, will not violate the Grantor’s certificate of incorporation or bylaws or, to the Grantor’s knowledge, any material judgment, order, writ, decree, statute, rule or regulation applicable to the Grantor.
​

11
​

​

6.Receivables. If any Event of Default shall have occurred and be continuing, the Collateral Agent may, or at the request and option of the Collateral Agent the Grantor shall, upon three (3) business days’ notice to Grantor, notify account debtors and other persons obligated on any of the Collateral of the security interest of the Collateral Agent, on behalf of the Lenders, in any account, chattel paper, general intangible, instrument, or other Collateral and that payment thereof is to be made directly to the Collateral Agent.
7.Covenants. The Grantor covenants as follows:
(a)The Grantor will not, without providing at least ten (10) days’ prior written notice to the Collateral Agent, change its legal name, identity, type of organization, jurisdiction of organization, corporate structure, location of its chief executive office or its principal place of business, or its organizational identification number. The Grantor will, prior to any change described in the preceding sentence, take all actions reasonably requested by the Collateral Agent to maintain the perfection and priority of the Collateral Agent’s security interest (for the benefit of the Lenders) in the Collateral.
(b)The Grantor shall, at its own cost and expense, defend title to the Collateral and the first priority lien and security interest of the Collateral Agent, for the benefit of the Lenders, therein against the claim of any person claiming against or through the Grantor and (i) shall maintain and preserve such perfected first priority security interest for so long as this Agreement shall remain in effect, (ii) shall not take any action, or omit to take an action, that would adversely affect such first priority lien and security interest of the Collateral Agent.
(c)The Grantor will not sell, offer to sell, dispose of, convey, assign or otherwise transfer, grant any option with respect to, restrict, or grant, create, permit, or suffer to exist any mortgage, pledge, lien, security interest, option, right of first offer, encumbrance, or other restriction or limitation of any nature whatsoever on, any of the Collateral or any interest therein except as expressly provided for herein or with the prior written consent of the Collateral Agent.
8.Collateral Agent Appointed Attorney-in-Fact. The Grantor hereby appoints the Collateral Agent as the Grantor’s attorney-in-fact, with full authority in the place and stead of the Grantor and in the name of the Grantor or otherwise, from time to time during the continuance of an Event of Default in the Collateral Agent’s discretion to take any action and to execute any instrument which the Collateral Agent may deem necessary or advisable to accomplish the purposes of this Agreement (but the Collateral Agent shall not be obligated to and shall have no liability to the Grantor or any third party for failure to do so or take action). This appointment, being coupled with an interest, shall be irrevocable. The Grantor hereby ratifies all that said attorneys shall lawfully do or cause to be done by virtue hereof.
9.Collateral Agent May Perform. If the Grantor fails to perform any obligation contained in this Agreement, the Collateral Agent may itself perform, or cause performance of, such obligation, and the expenses of the Collateral Agent incurred in connection therewith shall be payable by the Grantor; provided that the Collateral Agent shall not be required to perform or discharge any obligation of the Grantor.
10.Reasonable Care. The Collateral Agent shall have no duty with respect to the care and preservation of the Collateral beyond the exercise of reasonable care. The Collateral Agent shall be deemed to have exercised reasonable care in the custody and preservation of the Collateral in its possession if the Collateral is accorded treatment substantially equal to that which the Collateral Agent accords its own property, it being understood that the Collateral Agent shall not have any responsibility for (a) ascertaining or taking action with respect to any claims, the nature or sufficiency of any payment or performance by any party under or pursuant to any agreement relating to the Collateral or other matters relative to any Collateral, whether or not the Collateral Agent has or is deemed to have knowledge of such matters, or (b) taking any necessary steps to preserve rights against any parties with respect to any Collateral. Nothing set forth in this Agreement, nor the exercise by the Collateral Agent of any of the rights and remedies hereunder, shall relieve the Grantor from the performance of any obligation on the Grantor’s part to be performed or observed in respect of any of the Collateral.
​

12
​

​

11.Remedies Upon Default.
(a)Subject to Section 12 below, if any Event of Default shall have occurred and be continuing, the Collateral Agent (itself or through a designee), without any other notice to or demand upon the Grantor, may assert all rights and remedies of a secured party under the UCC or other applicable law, including, without limitation, the right to take possession of, hold, collect, sell, lease, deliver, grant options to purchase or otherwise retain, liquidate, or dispose of all or any portion of the Collateral; provided that in exercising such remedies the Collateral Agent agrees that it will conduct a sale of the Collateral pursuant to this Section 11 and shall distribute the proceeds resulting therefrom pro rata among the Lenders based on the aggregate principal amount of the Notes held by such Lenders. If notice prior to disposition of the Collateral or any portion thereof is necessary under applicable law, written notice mailed to the Grantor at its notice address as provided in Section 15 hereof ten (10) days prior to the date of such disposition shall constitute reasonable notice, but notice given in any other reasonable manner shall be sufficient. So long as the sale of the Collateral is made in a commercially reasonable manner, the Collateral Agent may sell such Collateral on such terms and to such purchaser(s) as the Collateral Agent, in its absolute discretion may choose, without assuming any credit risk and without any obligation to advertise or give notice of any kind other than that necessary under applicable law. Without precluding any other methods of sale, the sale of the Collateral or any portion thereof shall have been made in a commercially reasonable manner if conducted in conformity with reasonable commercial practices of creditors disposing of similar property. At any sale of the Collateral, if permitted by applicable law, the Collateral Agent or any of the Lenders may be the purchaser, licensee, assignee, or recipient of the Collateral or any part thereof and shall be entitled, for the purpose of bidding and making settlement or payment of the purchase price for all or any portion of the Collateral sold, assigned, or licensed at such sale, to use and apply any of the Secured Obligations as a credit on account of the purchase price of the Collateral or any part thereof payable at such sale. To the extent permitted by applicable law, the Grantor waives all claims, damages, and demands it may acquire against the Collateral Agent arising out of the exercise by it of any rights hereunder. The Grantor hereby waives and releases to the fullest extent permitted by law any right or equity of redemption with respect to the Collateral, whether before or after sale hereunder, and all rights, if any, of marshalling the Collateral and any other security for the Secured Obligations or otherwise. At any such sale, unless prohibited by applicable law, the Collateral Agent, the Lenders or any custodian may bid for and purchase all or any part of the Collateral so sold free from any such right or equity of redemption. Neither the Collateral Agent nor any custodian shall be liable for failure to collect or realize upon any or all of the Collateral or for any delay in so doing, nor shall it be under any obligation to take any action whatsoever with regard thereto. The Grantor agrees that it would not be commercially unreasonable for the Collateral Agent to dispose of the Collateral or any portion thereof by utilizing internet sites that provide for the auction of assets of the type included in the Collateral or that have the reasonable capability of doing so, or that match buyers and sellers of assets. The Collateral Agent shall not be obligated to clean up or otherwise prepare the Collateral for sale.
(b)If any Event of Default shall have occurred and be continuing, any cash held by the Collateral Agent, for the benefit of the Lenders, as Collateral and all cash Proceeds received by the Collateral Agent in respect of any sale of, collection from, or other realization upon all or any part of the Collateral shall be applied in whole or in part by the Collateral Agent to the payment of expenses incurred by the Collateral Agent in connection with the foregoing or incidental to the care or safekeeping of any of the Collateral or in any way relating to the Collateral or the rights of the Collateral Agent hereunder, including reasonable attorneys’ fees, and the balance of such proceeds shall be applied or set off against all or any part of the Secured Obligations pro rata to each Lender based on the aggregate outstanding principal amount of the Notes held by the Lenders. Any surplus of such cash or cash Proceeds held by the Collateral Agent or the Lenders and remaining after payment in full of all the Secured Obligations shall be paid over to the Grantor or to whomsoever may be lawfully entitled to receive such surplus. The Grantor shall remain liable for any deficiency if such cash and the cash Proceeds of any sale or other realization of the Collateral are insufficient to pay the Secured Obligations and the fees and other charges of any attorneys employed by the Collateral Agent to collect such deficiency.
​

13
​

​

(c)If the Collateral Agent shall determine to exercise its rights to sell all or any of the Collateral pursuant to this Section, the Grantor agrees that, upon request of the Collateral Agent, the Grantor will, at its own expense, do or cause to be done all such acts and things as may be necessary to make such sale of the Collateral or any part thereof valid and binding and in compliance with applicable law.
12.Collateral Agent.
(a)The Collateral Agent shall not have any duties or obligations except those expressly set forth in the Loan Documents. Without limiting the generality of the foregoing, (a) the Collateral Agent shall not be subject to any fiduciary or other implied duties, regardless of whether an Event of Default has occurred and is continuing, and (b) the Collateral Agent shall not have any duty to take any discretionary action or exercise any discretionary powers, except discretionary rights and powers expressly contemplated hereby that the Collateral Agent is required to exercise in writing by the Lead Lender. The Collateral Agent shall not be liable for any action taken or not taken by it with the consent or at the request of the Lead Lender or in the absence of its own gross negligence or willful misconduct. The Collateral Agent shall not be deemed to have knowledge of any Event of Default unless and until written notice thereof is given to the Collateral Agent by Grantor, and the Collateral Agent shall not be responsible for or have any duty to ascertain or inquire into (i) any statement, warranty or representation made by Grantor in this Agreement or in the Purchase Agreement or the Notes, (ii) the contents of any certificate, report or other document delivered thereunder or in connection therewith, (iii) the performance or observance of any of the covenants, agreements or other terms or conditions set forth in this Agreement or in the Purchase Agreement or the Notes, (iv) the validity, enforceability, effectiveness or genuineness of this Agreement, the Purchase Agreement, the Notes or any other agreement, instrument or document, or (v) the satisfaction of any condition set forth in this Agreement or in the Purchase Agreement or the Notes, other than to confirm receipt of items expressly required to be delivered to such Agent.
(b)The Collateral Agent shall be entitled to rely upon, and shall not incur any liability for relying upon, any notice, request, certificate, consent, statement, instrument, document or other writing believed by it to be genuine and to have been signed or sent by the proper person. The Collateral Agent may also rely upon any statement made to it orally or by telephone and believed by it to have been made by the proper person, and shall not incur any liability for relying thereon.  The Collateral Agent may consult with legal counsel (who may be counsel for the Borrowers), independent accountants and other experts selected by it, and shall not be liable for any action taken or not taken by it in accordance with the advice of any such counsel, accountants or experts.
13.No Waiver and Cumulative Remedies. Neither the Collateral Agent nor any Lender shall, by any act (except by a written instrument pursuant to Section 14), delay, indulgence, omission, or otherwise be deemed to have waived any right or remedy hereunder or to have acquiesced in any Default or Event of Default. All rights and remedies herein provided are cumulative and are not exclusive of any rights or remedies provided by law.
14.Amendments. None of the terms or provisions of this Agreement may be amended, modified, supplemented, terminated, or waived, and no consent to any departure by the Grantor therefrom shall be effective unless the same shall be in writing and signed by the Lead Lender and the Grantor, and then such amendment, modification, supplement, waiver, or consent shall be effective only in the specific instance and for the specific purpose for which made or given.
15.Addresses For Notices. All notices and other communications provided for in this Agreement shall be in writing and shall be given in the manner and become effective as set forth in the Purchase Agreement, and addressed to the respective parties at their addresses as specified on the signature pages hereof or as to either party at such other address as shall be designated by such party in a written notice to each other party.
​

14
​

​

16.Continuing Security Interest; Further Actions. This Agreement shall create a continuing first priority lien and security interest in the Collateral and shall (a) subject to Section 17, remain in full force and effect until payment and performance in full of the Secured Obligations, (b) be binding upon the Grantor, its successors, and assigns, and (c) inure to the benefit of the Collateral Agent, the Lenders and their respective successors, transferees, and assigns; provided that the Grantor may not assign or otherwise transfer any of its rights or obligations under this Agreement without the prior written consent of the Collateral Agent.
17.Termination; Release. On the date on which all Secured Obligations have been paid and performed in full, the Collateral Agent will, at the request and sole expense of the Grantor, (a) duly assign, transfer, and deliver to or at the direction of the Grantor (without recourse and without any representation or warranty) such of the Collateral as may then remain in the possession of the Collateral Agent or the Lenders, together with any monies at the time held by the Collateral Agent or the Lenders hereunder, and (b) execute and deliver to the Grantor a proper instrument or instruments acknowledging the satisfaction and termination of this Agreement.
18.Governing Law. This Agreement and all actions arising out of or in connection with this Note shall be governed by and construed in accordance with the laws of the State of New York without regard to the conflicts of law provisions of the State of New York, or of any other state.
19.Jurisdiction and Venue. The Collateral Agent and the Company irrevocably consent to the exclusive jurisdiction of, and venue in, the state courts in New York County in the State of New York (or in the event of exclusive federal jurisdiction, the courts of the Eastern District of New York), in connection with any matter based upon or arising out of this Agreement or the matters contemplated herein, and agree that process may be served upon them in any manner authorized by the laws of the State of New York for such persons.
20.Counterparts. This Agreement and any amendments, waivers, consents, or supplements hereto may be executed in counterparts (and by different parties hereto in different counterparts), each of which shall constitute an original, but all taken together shall constitute a single contract. Delivery of an executed counterpart of a signature page to this Agreement by facsimile or in electronic (i.e., “pdf” or “tif”) format shall be effective as delivery of a manually executed counterpart of this Agreement. This Agreement constitutes the entire contract among the parties with respect to the subject matter hereof and supersede all previous agreements and understandings, oral or written, with respect thereto.
[Signature Page Follows]
​

15
​

​

IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first above written.
	​
​
​

	​

	​

	​
	TSU INC. (D/B/A DISPLAY) as Grantor

	​
	​
	​

	​
	​
	​

	​
	By
	​

	​
	​
	​

	​
	Name:

	​
	​

	​
	Title:

	​
	Address for Notices:

	​
	75 North Water Street

	​
	Norwalk, CT 06854

	​
	​

	​
	​

	​
​
​

	​

	​

	​
	BLACK, INC., as Collateral Agent

	​
	​
	​

	​
	​
	​

	​
	By
	​

	​
	​
	​

	​
	Name:

	​
	​

	​
	Title:

	​
	Address for Notices:

	​
	100 Shephard Avenue East, Suite 502

	​
	Toronto, Ontario, Canada  M2N 6N5

​

16
​

​

Exhibit C
FORM OF WARRANT
THIS WARRANT AND THE SECURITIES ISSUABLE UPON THE EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED, HYPOTHECATED, OR OTHERWISE TRANSFERRED EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT REGISTRATION IS NOT REQUIRED UNDER SUCH ACT OR UNLESS SOLD PURSUANT TO RULE 144 UNDER SUCH ACT.
	​

	​

	​

	Date of Issuance
	​
	Void after

	_______ __, 2021
	​
	              , 2026

​
TSU INC. (D/B/A DISPLAY)
 WARRANT TO PURCHASE SHARES OF COMMON STOCK
In connection with the secured promissory note sold by tsu Inc. (d/b/a display), a Delaware corporation (the “Company”), purchased by __________ or its assigns (the “Holder”) pursuant to the Note and Warrant Purchase Agreement dated as of June 1, 2021 (the “Purchase Agreement”), this Warrant is issued to the Holder.
1.Purchase of Common Stock.
(a)Issuable Common Stock. Subject to the terms and conditions set forth herein, the Holder is entitled, upon surrender of this Warrant at the principal office of the Company (or at such other place as the Company shall notify the Holder in writing), to purchase common stock of the Company, par value $.001 (the “Common Stock”), in an amount as determined in Section 2.
(b)Exercise Price. The exercise price for the Common Stock shall be $1.86 per share (the “Exercise Price”). The Common Stock and the Exercise Price shall be subject to adjustment pursuant to Section 10 hereof.
2.Common Stock Exercisable Pursuant to Warrant. The Holder shall have the right to purchase up to _________shares of Common Stock.
3.Exercise Period. This Warrant shall be exercisable, in whole but not in part, until the fifth (5th) anniversary of the Date of Issuance set forth above (the “Exercise Period”); provided, however, that this Warrant shall no longer be exercisable and become null and void upon the earliest of (a) the consummation of the Company’s sale of its Common Stock or other securities in the Company’s first underwritten public offering pursuant to an effective registration statement under the Securities Act of 1933, as amended (the “Act”) (other than a registration statement relating either to sale of securities to employees of the Company pursuant to its stock option, stock purchase or similar plan or a SEC Rule 145 transaction) (an “Initial Public Offering”) or (b) (a) any consolidation or merger of the Company with or into any other corporation or other entity or person, or any other corporate reorganization, other than any such consolidation, merger or reorganization in which the stockholders of the Company immediately prior to such consolidation, merger or reorganization, continue to hold at least a majority of the voting power of
(Signature page for Security Agreement)
​

17
​

​

the surviving entity in substantially the same proportions (or, if the surviving entity is a wholly owned subsidiary, its parent) immediately after such consolidation, merger or reorganization; (b) any transaction or series of related transactions to which the Company is a party in which in excess of 50% of the Company’s voting power is transferred (a “Deemed Liquidation Event”).  In the event of an Initial Public Offering or Deemed Liquidation Event, the Company shall notify the Holder at least ten (10) business days prior to the consummation of such Initial Public Offering or Deemed Liquidation Event.
4.Method of Exercise.
(a)While this Warrant remains outstanding and exercisable in accordance with Section 2 above, the Holder may exercise, in whole, the purchase rights evidenced hereby. Such exercise shall be effected by:
(i)the surrender of the Warrant, together with a duly executed copy of the Notice of Exercise attached hereto, to the Secretary of the Company at its principal office (or at such other place as the Company shall notify the Holder in writing);
(ii)the payment to the Company of an amount equal to the aggregate Exercise Price for the number of shares of Common Stock being purchased.
(b)Each exercise of this Warrant shall be deemed to have been effected immediately prior to the close of business on the day on which this Warrant is surrendered to the Company as provided in Section 4.a) above. At such time, the person or persons in whose name or names any certificate for the Common Stock shall be issuable upon such exercise as provided in Section 4.c) below shall be deemed to have become the holder or holders of record of the Common Stock represented by such certificate.
(c)As soon as practicable after the exercise of this Warrant in whole, the Company at its expense will cause to be issued in the name of, and delivered to, the Holder, or as such Holder (upon payment by such Holder of any applicable transfer taxes) may direct a certificate or certificates for the number of Common Stock to which such Holder shall be entitled.
5.Net Exercise. In lieu of exercising this Warrant for cash, the Holder may elect to receive shares equal to the value of this Warrant (or the portion thereof being exercised) by surrender of this Warrant at the principal office of the Company together with notice of such election (a “Net Exercise”). A Holder who Net Exercises shall have the rights described in Sections 4.b) and 4.c) hereof, and the Company shall issue to such Holder a number of Common Stock computed using the following formula:

Where
		X =
	The number of shares of Common Stock to be issued to the Holder.

		Y =
	The number of shares Common Stock purchasable under this Warrant.

		A =
	The fair market value of one (1) share of Common Stock (at the date of such calculation).

		B =
	The Exercise Price (as adjusted to the date of such calculation).

​

18
​

​

For purposes of this Section 5, the fair market value of a Share shall mean the average of the closing prices of the Common Stock quoted on any exchange or electronic securities market on which the Common Stock are listed, as published in The Wall Street Journal for the thirty (30) trading days prior to the date of determination of fair market value (or such shorter period of time during which such Common Stock were traded on such exchange). In the event that this Warrant is exercised pursuant to this Section 5 in connection with the Initial Public Offering, the fair market value per Share shall be equal to the per share offering price to the public of the Initial Public Offering. If the  Stock are not traded on an exchange or an electronic securities market, the fair market value shall be the price per Share that the Company could obtain from a willing buyer for Common Stock sold by the Company from authorized but unissued Common Stock, as such prices shall be determined in good faith by the Company’s Board of Directors.
6.Automatic Exercise. If the Holder has not elected to exercise this Warrant prior to expiration of this Warrant pursuant to Section 3 or upon the end of the Exercise Period, then this Warrant shall automatically (without any act on the part of the Holder) be exercised pursuant to Section 5 effective immediately prior to the expiration of the Warrant to the extent such net issue exercise would result in the issuance of the Common Stock, unless Holder shall earlier provide written notice to the Company that the Holder desires that this Warrant expire unexercised. If this Warrant is automatically exercised, the Company shall notify the Holder of the automatic exercise as soon as reasonably practicable, and the Holder shall surrender the Warrant to the Company in accordance with the terms hereof.
7.Representations and Warranties of the Company; Covenants of the Company. In connection with the transactions provided for herein, the Company hereby represents and warrants to the Holder that:
(a)Organization, Good Standing, and Qualification. The Company is a corporation duly organized, validly existing, and in good standing under the laws of the State of Delaware and has all requisite corporate power and authority to carry on its business as now conducted. The Company is duly qualified to transact business and is in good standing in each jurisdiction in which the failure to so qualify would have a material adverse effect on its business or properties.
(b)Authorization. Except as may be limited by applicable bankruptcy, insolvency, reorganization, or similar laws relating to or affecting the enforcement of creditors’ rights, all corporate action has been taken on the part of the Company, its officers, directors, and stockholders necessary for the authorization, execution and delivery of this Warrant. The Company has taken all corporate action required to make all the obligations of the Company reflected in the provisions of this Warrant the valid and enforceable obligations they purport to be. The issuance of this Warrant will not be subject to preemptive rights of any stockholders of the Company.
8.Representations and Warranties of the Holder. In connection with the transactions provided for herein, the Holder hereby represents and warrants to the Company that:
(a)Authorization. Holder represents that it has full power and authority to enter into this Warrant. This Warrant constitutes the Holder’s valid and legally binding obligation, enforceable in accordance with its terms, except as may be limited by (i) applicable bankruptcy, insolvency, reorganization, or similar laws relating to or affecting the enforcement of creditors’ rights and (ii) laws relating to the availability of specific performance, injunctive relief or other equitable remedies.
(b)Purchase Entirely for Own Account. The Holder acknowledges that this Warrant is entered into by the Company in reliance upon such Holder’s representation to the Company that the Warrant and the Common Stock (collectively, the “Securities”) will be acquired for investment for the Holder’s own account, not as a nominee or agent, and not with a view to the resale or distribution of any part thereof, and that the Holder has no present intention of selling, granting any participation in or
​

19
​

​

otherwise distributing the same. By acknowledging this Warrant, the Holder further represents that the Holder does not have any contract, undertaking, agreement, or arrangement with any person to sell, transfer or grant participations to such person or to any third person, with respect to the Securities.
(c)Disclosure of Information. The Holder acknowledges that it has received all the information it considers necessary or appropriate for deciding whether to acquire the Securities. The Holder further represents that it has had an opportunity to ask questions and receive answers from the Company regarding the terms and conditions of the offering of the Securities.
(d)Investment Experience. The Holder is an investor in securities of companies in the development stage and acknowledges that it is able to fend for itself, can bear the economic risk of its investment, and has such knowledge and experience in financial or business matters that it is capable of evaluating the merits and risks of the investment in the Securities. If other than an individual, the Holder also represents it has not been organized solely for the purpose of acquiring the Securities.
(e)Accredited Investor. The Holder is an “accredited investor” within the meaning of Rule 501 of Regulation D, as presently in effect, as promulgated by the Securities and Exchange Commission (the “SEC”) under the Act.
(f)Restricted Securities. The Holder understands that the Securities are characterized as “restricted securities” under the federal securities laws inasmuch as they are being acquired from the Company in a transaction not involving a public offering and that under such laws and applicable regulations such securities may be resold without registration under the Act, only in certain limited circumstances. In this connection, the Holder represents that it is familiar with Rule 144, as presently in effect, as promulgated by the SEC under the Act (“Rule 144”), and understands the resale limitations imposed thereby and by the Act.
(g)Legends. It is understood that the Securities may bear the following legend:
“THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED, HYPOTHECATED, OR OTHERWISE TRANSFERRED EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT REGISTRATION IS NOT REQUIRED UNDER SUCH ACT OR UNLESS SOLD PURSUANT TO RULE 144 UNDER SUCH ACT.
THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO A VOTING TRUST AGREEMENT DATED AS OF AUGUST 21, 2019 ("VOTING TRUST AGREEMENT), A COPY OF WHICH IS ON FILE WITH AND MAY BE OBTAINED FROM THE SECRETARY OF THE COMPANY AT NO CHARGE.  THE SHARES REPRESENTED BY THIS CERTIFICATE MAY BE TRANSFERRED ONLY IN ACCORDANCE WITH THE VOTING TRUST AGREEMENT.”
9.State Commissioners of Corporations. THE SALE OF THE SECURITIES WHICH ARE THE SUBJECT OF THIS WARRANT HAS NOT BEEN QUALIFIED WITH THE COMMISSIONER OF CORPORATIONS OF THE STATE OF CALIFORNIA AND THE ISSUANCE OF SUCH SECURITIES OR THE PAYMENT OR RECEIPT OF ANY PART OF THE CONSIDERATION FOR SUCH SECURITIES PRIOR TO SUCH QUALIFICATION IS UNLAWFUL, UNLESS THE SALE OF SECURITIES IS EXEMPT FROM QUALIFICATION BY SECTION 25100, 25102 OR 25105 OF THE CALIFORNIA CORPORATIONS CODE. THE RIGHTS OF ALL PARTIES TO THIS WARRANT
​

20
​

​

ARE EXPRESSLY CONDITIONED UPON SUCH QUALIFICATION BEING OBTAINED, UNLESS THE SALE IS SO EXEMPT.
10.Adjustment of Exercise Price and Number of Common Stock. The number of Common Stock purchasable upon exercise of this Warrant and the Exercise Price shall be subject to adjustment from time to time as follows:
(a)Subdivisions, Combinations and Other Issuances. If the Company shall at any time prior to the expiration of this Warrant subdivide its Common Stock, by split-up or otherwise, or combine its Common Stock, or issue additional shares of its Common Stock as a dividend, the number of Common Shares issuable on the exercise of this Warrant shall forthwith be proportionately increased in the case of a subdivision or stock dividend, or proportionately decreased in the case of a combination. Appropriate adjustments shall also be made to the Exercise Price payable per share, but the aggregate Exercise Price payable for the total number of shares of Common Stock purchasable under this Warrant (as adjusted) shall remain the same. Any adjustment under this Section 10.a) shall become effective at the close of business on the date the subdivision or combination becomes effective, or as of the record date of such dividend, or in the event that no record date is fixed, upon the making of such dividend.
(b)Reclassification, Reorganization and Consolidation. In case of any reclassification, capital reorganization or change in the capital stock of the Company (other than as a result of a subdivision, combination or stock dividend provided for in Section 10.a) above), then, as a condition of such reclassification, reorganization or change, lawful provision shall be made, and duly executed documents evidencing the same from the Company or its successor shall be delivered to the Holder, so that the Holder shall have the right at any time prior to the expiration of this Warrant to purchase, at a total price equal to that payable upon the exercise of this Warrant, the kind and amount of shares of stock and other securities or property receivable in connection with such reclassification, reorganization or change by a holder of the same number and type of securities as were purchasable as Common Stock by the Holder immediately prior to such reclassification, reorganization or change. In any such case appropriate provisions shall be made with respect to the rights and interest of the Holder so that the provisions hereof shall thereafter be applicable with respect to any shares of stock or other securities or property deliverable upon exercise hereof, and appropriate adjustments shall be made to the Exercise Price per Share payable hereunder, provided the aggregate Exercise Price shall remain the same.
(c)Notice of Certain Events. When any adjustment is required to be made in the number or kind of shares purchasable upon exercise of the Warrant, or in the Exercise Price, the Company shall promptly notify the Holder of such event and of the number of shares of Common Stock or other securities or property thereafter purchasable upon exercise of this Warrant.
11.No Fractional Common Stock or Scrip. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant, but in lieu of such fractional shares the Company shall make a cash payment therefor on the basis of the Exercise Price then in effect.
12.No Stockholder Rights. Prior to exercise of this Warrant, the Holder shall not be entitled to any rights of a stockholder with respect to the Common Stock, including (without limitation) the right to vote such Common Stock, receive dividends or other distributions thereon, exercise preemptive rights or be notified of stockholder meetings, and, except as otherwise provided in this Warrant, such Holder shall not be entitled to any stockholder notice or other communication concerning the business or affairs of the Company.
13.Transfer of Warrant. Subject to compliance with applicable federal and state securities laws and any other contractual restrictions between the Company and the Holder contained herein, this
​

21
​

​

Warrant and all rights hereunder are transferable in whole by the Holder to any person or entity upon written notice to the Company. Within a reasonable time after the Company’s receipt of an executed Assignment Form in the form attached hereto, the transfer shall be recorded on the books of the Company upon the surrender of this Warrant, properly endorsed, to the Company at its principal offices, and the payment to the Company of all transfer taxes and other governmental charges imposed on such transfer. In the event of a partial transfer, the Company shall issue to the new holders one (1) or more appropriate new warrants.
14.Governing Law. This Warrant shall be governed by and construed under the laws of the State of Delaware as applied to agreements among Delaware residents, made and to be performed entirely within the State of Delaware.
15.Successors and Assigns. The terms and provisions of this Warrant shall inure to the benefit of, and be binding upon, the Company and the holders hereof and their respective successors and assigns.
16.Counterparts. This Warrant may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.
17.Titles and Subtitles. The titles and subtitles used in this Warrant are used for convenience only and are not to be considered in construing or interpreting this Warrant.
18.Notices.
(a)All notices and other communications given or made pursuant hereto shall be in writing and shall be deemed effectively given: (a) upon personal delivery to the party to be notified, (b) when sent by confirmed electronic mail or facsimile if sent during normal business hours of the recipient, and if not so confirmed, then on the next business day, (c) five (5) days after having been sent by registered or certified mail, return receipt requested, postage prepaid, or (d) one (1) day after deposit with a nationally recognized overnight courier, specifying next day delivery, with written verification of receipt. All communications shall be sent to the respective parties at the addresses set forth on the signature pages hereto (or at such other addresses as shall be specified by notice given in accordance with this Section 18):
(b)Prior to the expiration of this Warrant, in the event the Company shall authorize (1) the voluntary liquidation, dissolution or winding up of the Company; or (2) any transaction resulting in the expiration of this Warrant; the Company shall send to the Holder of this Warrant at least ten (10) days prior written notice of the expected effective date of any such other event specified in clause (1) or (2), as applicable. The notice provisions set forth in this section may be shortened or waived prospectively or retrospectively by the consent of the Holder of this Warrant.
19.Finder’s Fee. Each party represents that it neither is nor will be obligated for any finder’s fee or commission in connection with this transaction. The Holder agrees to indemnify and to hold harmless the Company from any liability for any commission or compensation in the nature of a finder’s fee (and the costs and expenses of defending against such liability or asserted liability) for which the Holder or any of its officers, partners, employees or representatives is responsible. The Company agrees to indemnify and hold harmless the Holder from any liability for any commission or compensation in the nature of a finder’s fee (and the costs and expenses of defending against such liability or asserted liability) for which the Company or any of its officers, employees or representatives is responsible.
​

22
​

​

20.Expenses. If any action at law or in equity is necessary to enforce or interpret the terms of this Warrant, the prevailing party shall be entitled to reasonable attorneys’ fees, costs, and necessary disbursements in addition to any other relief to which such party may be entitled.
21.Entire Agreement; Amendments and Waivers. This Warrant and any other documents delivered pursuant hereto constitute the full and entire understanding and agreement between the parties with regard to the subjects hereof and thereof. This Warrant may be amended, waived, or modified by the written consent of the Company and the Lead Lender (as defined in the Note). The observance of any term of this Warrant may also be waived (either generally or in a particular instance and either retroactively or prospectively) with the written consent of the Company and the Holder; or if this Warrant has been assigned in part, by the holders or rights to purchase a majority of the shares originally issuable pursuant to this Warrant.
22.Severability. If any provision of this Warrant is held to be unenforceable under applicable law, such provision shall be excluded from this Warrant and the balance of the Warrant shall be interpreted as if such provision were so excluded and shall be enforceable in accordance with its terms.
23.No Impairment. The Company will not, by any voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant to be observed or performed by the Company, but will at all times in good faith assist in the carrying out of all the provisions of this Warrant and in the taking of all such action as may be necessary or appropriate in order to protect the rights of the Holder of this Warrant against impairment.
(Signature page follows)
​

23
​

​

IN WITNESS WHEREOF, the parties have executed this Warrant as of the date first written above.
tsu Inc. (d/b/a display)
a Delaware corporation
​
	​

	​

	​

	​
	By:
	​

	​
	Name:
	​

	​
	Title:
	​

​
ACKNOWLEDGED AND AGREED:
HOLDER
	​
​
​

	​

	​
	​

	(Print investor name)
	​

	​
	​

	(Signature)
	​

	​
	​

	(Print name of signatory, if signing for an entity)
	​

	​
	​

	(Signature page for Warrant)
	​

​

24
​

​

(Print title of signatory, if signing for an entity)
	​
	​
	​

	(Address)
	​
	​

​
(Signature page for Warrant)
​
​

25
​

​

NOTICE OF EXERCISE
tsu Inc. (d/b/a display)
Attention: Chief Financial Officer
The undersigned hereby elects to purchase, pursuant to the provisions of the Warrant, as follows:
		q
	_____________ Common Stock pursuant to the terms of the attached Warrant, and tenders herewith payment in cash of the Exercise Price of such Common Stock in full, together with all applicable transfer taxes, if any.

		q
	Net Exercise the attached Warrant with respect to __________ Common Stock.

The undersigned hereby represents and warrants that Representations and Warranties in Section 8 of the Warrant are true and correct as of the date hereof.
HOLDER:
	​
​
​

	​

	​

	​

	​

	Date:
	​
	​
	By:
	​

	​
	​
	​

	​
	​
	Address:
	​

	​
	​
	​

	​
	​
	​

​
	Name in which shares should be registered:
	​

	​
	​

	​
	​

​

26
​

​

ASSIGNMENT FORM
(To assign the foregoing Warrant, execute this form and supply required information. Do not use this form to purchase shares.)
FOR VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to
	Name:
	​

	(Please Print)

​
	Address:
	​

	(Please Print)

​
Dated: _________________
	Holder’s

	Signature:
	​

​
	Holder’s

	Address:
	​

​
NOTE: The signature to this Assignment Form must correspond with the name as it appears on the face of the Warrant. Officers of corporations and those acting in a fiduciary or other representative capacity should provide proper evidence of authority to assign the foregoing Warrant.
(Signature page for Warrant)

27
​Exhibit 10.12
ASSET PURCHASE AGREEMENT
THIS ASSET PURCHASE AGREEMENT (this “Agreement”) is made as of the 12th day of October 2021 by and between LookWithUs.com, Inc. a Delaware corporation (“Seller”) and tsu Inc. (d/b/a Display), a Delaware corporation (“Purchaser”).
WHEREAS, the Seller is the owner of the Patent, FileWag Technology and Documentation (each as defined below),
WHEREAS, the Purchaser has had ample time to investigate and perform due diligence on the Patent, FileWag Technology and Documentation,
WHEREAS, the parties hereto desire to enter into this Agreement pursuant to which Purchaser will acquire from Seller, and Seller shall sell to Purchaser, all of Seller’s rights and assets in and to its technology (the “Business”) including, without limitation, all rights, title and interest in and to the Patent, FileWag Technology and Documentation, upon the terms and subject to the conditions hereinafter set forth;
NOW, THEREFORE, in consideration of the terms, conditions, representations and covenants as herein set forth and for good and valuable consideration, the sufficiency of which is hereby acknowledged, the parties hereto hereby agree as follows:
SECTION 1.Definitions.  As used herein, the following terms shall have the following meanings unless the context otherwise requires.
“Affiliates” means, with respect to Purchaser or Seller, those Persons which are controlled by, controlling or under common control with, such Person.
“Assets” shall have the meaning set forth in Section 2(a) below.
“Assigned Patent Rights” shall have the meaning set forth in Section 2(a)(ii) below.
“Business” has the meaning set forth in the “WHEREAS” clause above.
“Business Intellectual Property” means the LookWithUs.com, Inc. patent and any derivation thereof and all other intellectual property specifically related to or focused on the Business (including without limitation patents, patent rights, copyrights, trade names, trademarks, logos, trade secret rights, technology, domain names and websites) that is owned or used by Seller or any of its Affiliates, specifically including, without limitation, the Patent, FileWag Technology and Documentation.
“Closing” shall mean the closing of the transactions contemplated by this Agreement.
“Closing Date” shall have the meaning set forth in Section 3(a) below.
“Common Shares” means common shares, par value $0.001, of Purchaser.
​
​

​
“Documentation” means the items listed in Exhibit A which pertain to the Patent and the FileWag Technology.
 “Effective Time” means 11:59 P.M. United States eastern standard time on the Closing Date.
“Encumbrances” means any mortgage, pledge, lien, security interest, restriction on use, claim, or other encumbrance, charge or adverse claim of any nature whatsoever on any asset, property or property interest.
“FileWag Technology” means a media collaboration system developed and owned by Seller which utilizes the Patent, including all computer programs and software identified in Exhibit B attached hereto, including, object code (including microcode) and/or source code.
“Governmental Entity” means any federal, state, or local governmental authority, quasi-governmental authority, instrumentality, court, government or self-regulatory organization or government tribunal or any regulatory, administrative or other agency, or any political or other subdivision, department or branch of any of the foregoing.
“Material Adverse Effect” on an entity or entities, as the case may be, means a material adverse effect on or material adverse change in (i) the financial condition, properties, business or results of operations of such entity or entities, as the case may be, or (ii) the ability of the relevant parties hereto to consummate the transactions contemplated hereby; provided, however, that a Material Adverse Effect shall not include any effect to the extent that Purchaser can demonstrate that such effect primarily resulted from (a) a change in Applicable Law or U.S. GAAP or any interpretation thereof, (b) a change in interest rates or economic, business or financial market conditions generally or (c) the announcement of this Agreement.
“Modifications” means any and all updates, modifications, revisions, improvements, versions and/or derivative works, to the Patent, FileWag Technology and/or Documentation.
“Organizational Documents” means such Person’s charter, by-laws, certificate of incorporation, limited liability company agreement, partnership agreement or other similar organizational document(s).
“Patent” means all rights, title and interest in and to United States Patent No. 8,826,375 B2 entitled Rich Media Collaboration System, Patent Date September 2, 2014, including any reissues, renewals, reexaminations, substitutions or extensions thereof, a copy of which is attached hereto as Exhibit C.
“Person” means any individual, corporation, partnership, limited liability company, joint venture, trust, business association, organization, Governmental Entity or other entity.
“Purchase Consideration” shall have the meaning set forth in Section 3(b) below.
“Representatives” means, as to any Person, its accountants, counsel, consultants, officers, directors, employees, agents and other advisers and representatives.
SECTION 2.Purchase and Sale of Assets; Assignment of Causes of Action.
​

2
​

(a)Purchased Assets.  Subject to the terms and conditions hereinafter set forth, Seller hereby sells, assigns, transfers, conveys and delivers to Purchaser, and Purchaser hereby purchases from Seller for the Purchase Consideration, all of Seller’s right, title and interest in and to the Assets, free and clear of any and all Encumbrances. The Assets purchased and assigned hereunder shall include, but not be limited to, the following assets, properties and rights relating to the Business owned by Seller (the “Assets”):
(i)The Business Intellectual Property;
(ii)The Patent and all inventions and discoveries described therein, including without limitation, all rights of Seller to collect any and all royalties under such Patent and all causes of action and enforcement rights, whether currently pending, filed or otherwise, for the Patent and all inventions and discoveries described therein, including without limitation all rights to pursue damages, injunctive relief and other remedies for past, current and future infringement of the Patent (collectively the “Assigned Patent Rights”);
(iii)The FileWag Technology; and
(iv)The Documentation.
SECTION 3.Closing; Purchase Consideration.
(a)Closing.  The Closing shall take place promptly following the execution of this Agreement upon delivery of the documents set forth in Sections 8 and 9 hereof and the satisfaction or waiver of all conditions to Closing set forth herein (the “Closing Date”).  The Closing shall be deemed effective as of the Effective Time on such Closing Date.
(b)Consideration Payable at Closing.  At the Closing, Purchaser agrees to pay to Seller the sum of Five Million Dollars ($5,000,000.00), payable in Common Shares at deemed equity value of $3.20 per share based on a valuation of the Purchaser of ($500,000,000) and the number of outstanding Common Shares of 156,267,177 as of September 24, 2021, which equals 1,562,500 Common Shares. (the “Purchase Consideration”).
(c)Allocation of Purchased Assets; Transfer Taxes.  The parties mutually agree that the Purchase Consideration for the Assets shall be allocated as follows: Four Million Dollars ($4,900,000.00) for the Patent, Ninety Thousand Dollars ($90,000.00) for the FileWag Technology and Documentation, and Ten Thousand ($10,000.00) for all of the other Assets other than the Patent, FileWag Technology and Documentation.  Seller covenants and agrees that it shall file all required tax forms and statements with their tax returns for the taxable year that includes the Closing Date.  All transfer and similar taxes payable in connection with the sale and transfer of the Assets shall be the responsibility of, and shall be paid by, Purchaser.
SECTION 4.No Assumption of Liabilities. Seller hereby acknowledges and agrees that Purchaser shall not be responsible for and does not assume any liabilities, duties or obligations relating to or arising out of the Business or any Assets while they were owned and controlled by Seller, all of which shall be retained by and shall be the exclusive obligation of the Seller.
SECTION 5.Further Assurances.  At any time, and from time to time, after the Closing Date, upon the reasonable request of Purchaser, Seller shall execute, acknowledge and deliver to Purchaser such other instruments as are necessary to evidence the conveyance, assignment and transfer of the Assets to Purchaser.
​

3
​

SECTION 6.Representations and Warranties of Seller.  Seller represents and warrants to Purchaser as follows:
(a)Organization; Qualification; Authority.  Seller is a corporation duly organized, validly existing, and in good standing under the laws of the State of Delaware.  Seller has all the requisite corporate power and authority to execute and deliver this Agreement and the other documents, instruments and agreements being entered into by it at the Closing (the “Seller Transaction Documents”), to perform its obligations hereunder and thereunder, and to consummate the transactions contemplated hereby and thereby. The execution, delivery and performance by Seller of this Agreement and each and every other Seller Transaction Document have been duly authorized by all requisite corporate action of Seller.  This Agreement and each and every Seller Transaction Document constitutes the legal, valid and binding obligation of Seller, enforceable against it in accordance with their respective terms.
(b)Ownership; Title of Assets; No Infringement. Seller owns all right, title and interest in, and has good and marketable title to all of the Assets, in each case free and clear of any Encumbrances including, without limitation, the Business Intellectual Property, the Patent, the Assigned Patent Rights, the FileWag Technology, the Documentation and all right, title, and interest to sue for infringement of the Patent. To the best of the Seller’s knowledge after due investigation, the Patent and the other Assets do not infringe on or misappropriate any patent or intellectual property rights of any third party.  If it is discovered in the future that the Patent unknowingly infringes an existing patent, such discovery shall not be deemed a breach of this Agreement. Seller has obtained and properly recorded previously executed assignments for the Patent as necessary to fully perfect its rights and title therein in accordance with governing law and regulations in each respective jurisdiction. To the best of the Seller’s knowledge after due investigation, there are no actions, suits, investigations, claims, or proceedings threatened, pending, or in progress relating in any way to the Assigned Patent Rights. There are no existing contracts, agreements, options, commitments, proposals, bids, offers, or rights with, to, or in any person to acquire any of the Business Intellectual Property, the Patent, the Assigned Patent Rights, the FileWag Technology and the Documentation.
(c)Enforcement: Seller has not put a third party on notice of actual or potential infringement of the Patent. Seller has no outstanding invitation to any third party to enter into a license of the Patent.
(d)No Restrictions on Rights; Conduct. Purchaser will not be subject to any covenant not to sue or similar restrictions on its enforcement or enjoyment of the Business Intellectual Property, the Patent, the Assigned Patent Rights, the FileWag Technology and the Documentation. None of Seller, prior owner or their respective agents or representatives have engaged in any conduct, or omitted to perform any necessary act, the result of which would invalidate the Patent or hinder its enforcement, including, without limitation, misrepresenting the Patent to a standard-setting organization.
(e)Patent Office Proceedings; Fees. The Patent is not currently involved in any reexamination, reissue, interference proceeding, or any similar proceeding, and no such proceedings are pending or threatened. All maintenance fees, annuities, and the like due or payable on the Patent have been timely paid.
SECTION 7.Representations and Warranties of Purchaser.  Purchaser represents and warrants to Seller as follows:
(a)Due Incorporation of Purchaser. Purchaser is a corporation duly incorporated, validly existing and in good standing under the laws of the State of Delaware, with all requisite corporate power and authority to carry on its business as it is currently conducted.
​

4
​

(b)Due Authorization of Transaction; Binding Obligation. Purchaser has all requisite corporate power and authority to execute and deliver this Agreement and any other documents to be entered into by it at the Closing (the “Purchaser Transaction Documents”), and to perform its obligations hereunder and consummate the transactions contemplated for it hereby, and the execution, delivery and performance of this Agreement by Purchaser have been duly authorized by all necessary corporate action on the part of Purchaser. This Agreement and the other Purchaser Transaction Documents have been duly executed and delivered by Purchaser and are the legal, valid and binding obligation of Purchaser enforceable against the Purchaser in accordance with their respective terms.
(c)Non-Contravention. The execution, delivery and performance of this Agreement by Purchaser and the consummation of the transactions contemplated hereby do not and will not contravene the Organizational Documents of Purchaser or violate, in any material respect, any Applicable Law and do not and will not conflict in any material respect with or result in a material breach of, or material default under, any contract, judgment, decree, order or ruling to which Purchaser is a party or by which it or any of its assets or properties is bound or affected.
(d)Government Approvals, Consents, and Filings. No approval, authorization, consent, order, filing, registration or notification is required to be obtained by Purchaser from, or made or given by Purchaser to, any Governmental Entity or other Person in connection with the execution, delivery and performance of this Agreement and the consummation of the transactions contemplated hereby.
(e)Litigation. (i) Purchaser is not engaged in, or a party to, or to the knowledge of Purchaser, threatened with, any legal action or other proceeding before any Governmental Entity, which, individually or in the aggregate, is reasonably likely to have a Material Adverse Effect on Purchaser and (ii) there are no outstanding orders, rulings, decrees, judgments or stipulations by or with any Governmental Entity (other than through general application) which, individually or in the aggregate, are reasonably likely to have a Material Adverse Effect on Purchaser.
SECTION 8.Closing Deliveries by Seller.  At the Closing, Seller shall execute and deliver or cause to be delivered to Purchaser the following, in form and substance reasonably satisfactory to Purchaser and Seller in the case of all documents:
(a)an incumbency certificate setting forth the names and respective signatures of the officers of Seller who have executed documents in connection with the Closing, certified by the Secretary or Assistant Secretary of Purchaser to be true and accurate as of the Closing Date; and
(b)such bills of sale, deeds, assignments and other good and sufficient instruments of assignment and transfer as shall be required or as may be appropriate in order to vest in Purchaser all of Seller’s right, title and interest in and to all of the Assets, including without limitation the Business Intellectual Property, the Patent, the Assigned Patent Rights, the FileWag Technology and the Documentation in the form attached as Exhibit D.
SECTION 9.Closing Deliveries by Purchaser.  At the Closing, Purchaser shall execute and deliver or cause to be delivered or issued to Seller the following, in form and substance reasonably satisfactory to Purchaser and Seller in the case of all documents:
(a)an incumbency certificate setting forth the names and respective signatures of the officers of Purchaser who have executed documents in connection with the Closing, certified by the Secretary or Assistant Secretary of Purchaser to be true and accurate as of the Closing Date; and
(b)the Purchase Consideration.
​

5
​

SECTION 10.Future Transfers of Purchaser Common Stock. From and after the Closing Date, Purchaser agrees to take any and all reasonable actions and to create and execute any and all documents reasonably necessary to effectuate the distribution of title to the Purchase Consideration, at such time in the future as the Seller may request, so that Seller may distribute the Purchase Consideration as a dividend to the owners of the Seller, including cancelling the Common Shares issued to the Seller and re-issuing such Common Shares in the names of the owners of Seller if requested by the Seller.
SECTION 11.Notices.  All notices to either party shall be in writing and delivered by hand, certified mail or overnight delivery to the address set forth by Seller and Purchaser below, or to such other address as either party shall designate by notice to the other party in accordance with this Section, and such notice shall be deemed effective upon delivery.
If to Seller:
LookWithUs.com, Inc.
5417 Ruthwood Drive
Calabasas, CA 91302
Attn:Mark Smith, Chief Executive Officer
Email:mark@lookwithus.com
If to Purchaser, to:
tsu Inc. (d/b/a Display
75 North Water Street,
Norwalk, CT 06854
Attn:   John Acunto
Email: j@displaysocial.com
SECTION 12.Purchaser Covenants.
(a)No Encumbrances.  From the Closing Date until the expiration of the Exercise Period (as such term is defined in that certain  Option Agreement, executed contemporaneously herewith) the Purchaser shall not, without the prior consent of Seller (which consent shall not be unreasonably withheld or delayed), sell, lease, hypothecate or otherwise transfer or dispose of all, or any part of the Business Intellectual Property.
(b)Right of First Negotiation.  After the Closing, in the event if Purchaser (i) makes an assignment for the benefit of creditors, (ii) files a voluntary petition in bankruptcy, Purchaser is adjudged a bankrupt or insolvent, or has entered against it an order for relief, in any bankruptcy or insolvency proceedings, (iii) consents to or files a petition or answer seeking for itself any reorganization, arrangement, composition, readjustment, liquidation, dissolution or similar relief under any statute, law or regulation, (iv) files an answer or other pleading admitting or failing to contest the material allegations of a petition filed against it in any bankruptcy or insolvency proceeding, (e) seeks, consents to or acquiesces in the appointment of a trustee, receiver, liquidator, sequestrator, custodian or any similar official of or for Purchaser or of all or any substantial part of its properties, (f) within sixty (60) days after the commencement of any proceeding against Purchaser seeking reorganization, arrangement, composition, readjustment, liquidation, dissolution or similar relief under any statute, law or regulation, the proceeding has not been dismissed, (g) within sixty (60) days after the appointment without Purchaser’s consent
​

6
​

or acquiescence of a trustee, receiver or liquidator of Purchaser or of all or any substantial part of its properties, the appointment is not vacated or stayed, or within sixty (60) days after the expiration of any such stay, the appointment is not vacated, or (h) Purchaser taking any action in furtherance of any of the foregoing, then Purchaser shall first notify Seller in writing, who will then have for a period of thirty (30) days thereafter, the exclusive right to enter into good faith negotiations with Purchaser for the purchase of the Assets.
SECTION 13.Indemnification.
(a)Indemnification by Seller.  From and after the Closing Date, and without limiting any other remedy available to Purchaser, Seller shall indemnify and hold harmless Purchaser, its affiliates and each of their respective officers, directors, agents and employees (the “Purchaser Indemnified Parties”) from and against any and all damages, losses, deficiencies, liabilities, obligations, commitments, costs or expenses of any kind or nature (including reasonable legal and other expenses) ("Reimbursable Amounts") incurred by any of the Purchaser Indemnified Parties arising from: (i) any claims arising from the sale of the Assets by Seller prior to the Closing Date; (ii) any failure by Seller to satisfy and/or discharge any obligations or liabilities of the Seller with respect to the sale of the Assets; (iii) any breach by Seller of any of its representations or warranties set forth in Section 6 above; and (iv) any breach by Seller of this Agreement, the Seller Transaction Documents or any ancillary document.
(b)Indemnification by Purchaser.  From and after the Closing Date, and without limiting any other remedy available to the Seller, Purchaser shall indemnify and hold harmless Seller, its affiliates and each of their respective officers, directors, agents and employees (the “Seller Indemnified Parties”) from and against any and all Reimbursable Amounts incurred by any of the Seller Indemnified Parties, arising from: (i) any breach by Purchaser of any of its representations or warranties set forth in Section 7 above; and (ii) any breach by Purchaser of this Agreement, the Purchaser Transaction Documents or any ancillary document.
SECTION 14.Miscellaneous.
(a)Press Releases, etc.  Purchaser has the right to issue one or more press releases announcing the completion of this transaction with the timing, the content and the dissemination to be determined by Purchaser.  Except as may otherwise be agreed to by Purchaser, Seller shall issue no press release or public announcement with respect to the subject matter of this Agreement, except as may be required to comply with applicable law or the requirements of any governmental entity and with the prior review and approval by Purchaser.
(b)Counterparts.  This Agreement may be executed in one or more counterparts, each of which when so executed shall be deemed an original of this Agreement and all of which together shall constitute one and the same agreement.
(c)Section and Other Headings; Interpretation.  The sections and other headings contained in this Agreement are for reference purposes only and shall not define, limit or extend the meaning or interpretation of this Agreement.  The word “including” in this Agreement means “including without limitation.” The word “or” in this Agreement is disjunctive but not necessarily exclusive.  All words in this Agreement will be construed to be of such gender or number as the circumstances require.
(d)Entire Agreement; Incorporation by Reference.  All schedules and exhibits attached hereto are incorporated by reference. This Agreement and the other documents referenced herein
​

7
​

contain the entire agreement between the parties with respect to the subject matter hereof and thereof and supersede all prior agreements and understandings, both written and oral, between the parties with respect to the subject matter hereof and thereof (including any confidentiality agreements and letters of intent or similar documents).
(e)Binding Effect.  This Agreement shall inure to the benefit of and be binding upon the parties and their respective successors and permitted assigns. Nothing in this Agreement, express or implied, is intended to confer on any Person other than the parties, or their respective successors or permitted assigns, any rights, remedies, obligations or liabilities under or by reason of this Agreement.
(f)Amendment or Modification.  This Agreement may not be amended, supplemented or otherwise modified by the parties in any manner, except by an instrument in writing signed by each of the parties hereto.
(g)Waiver.  The failure of any party to enforce at any time any of the provisions of this Agreement shall in no way be construed to be a waiver of any such provision, nor in any way to affect the validity of this Agreement or any part thereof or the right of any party thereafter to enforce each and every such provision, and the single or partial exercise of any right hereunder by any party shall not preclude any other or further exercise of such right or any other right by such party or the other party.  No waiver by any Party of any breach of this Agreement will be deemed to extend to any other breach hereunder or affect in any way any rights arising by virtue of any other breach.  No waiver of any provision of this Agreement will be valid unless the waiver is in writing and signed by the waiving party.
(h)Severability.  If any provision of this Agreement shall be determined by a court of competent jurisdiction to be invalid or unenforceable in any jurisdiction, such determination shall not affect the validity or enforceability of the remaining provisions of this Agreement in such jurisdiction.  If any provision of this Agreement, or the application thereof to any Person or entity or any circumstance, is found to be invalid or unenforceable in any jurisdiction, (a) a suitable and equitable provision shall be substituted therefor in order to carry out, so far as may be valid or enforceable, the unenforceable provision and (b) the remainder of this Agreement and the application of such provision to other Persons, entities or circumstances shall not be affected by such invalidity or unenforceability, nor shall such invalidity or unenforceability affect the validity or enforceability of such provision, or the application thereof, in any other jurisdiction.
(i)Expenses.  All expenses incurred by the parties hereto in connection with the negotiation of this Agreement and documentation of the transactions contemplated hereby, including without limitation, all expenses of counsel and accountants employed by the parties, shall be borne solely and entirely by the party which has incurred such expense.  This provision shall not limit the right to indemnification of any party for expenses of counsel and other experts and advisors.
(j)Assignment.  This Agreement may not be assigned (in whole or in part) by either party without the prior written consent of the other party; provided, that either party may assign this Agreement to an Affiliate or to any Person that succeeds to substantially all of the assets or business of such party (irrespective of the form of transaction).
(k)Governing Law; Waiver of Trial by Jury.  This Agreement shall be governed by and construed in accordance with the laws of the State of New York without regard to its conflict of laws principles.  The parties agree to be subject to personal jurisdiction in the courts of the State of New York. EACH OF THE PARTIES HEREBY AGREES TO IRREVOCABLY AND UNCONDITIONALLY WAIVE TRIAL BY JURY IN ANY JUDICIAL PROCEEDING BETWEEN THE PARTIES ARISING OUT OF OR RELATED TO THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT.
​

8
​

(l)Survival. The terms of this Agreement that either explicitly or implicitly are intended to survive shall survive termination or expiration of this Agreement, in whole or part, for any reason whatsoever including but not limited to sections 6, 7, 12 and 13.
IN WITNESS WHEREOF, the parties hereto have executed this Agreement, on the date first set forth above, intending to be legally bound thereby.
	​

	​

	​

	​
	SELLER: LookWithUs.com, Inc.

	​
	​

	​
	​
	​

	​
	By:
	 /s/ Mark Smith

	​
	Name: Mark Smith

	​
	Title: CEO

	​
	​
	​

	​
	PURCHASER: tsu Inc. (d/b/a Display)

	​
	​

	​
	​
	​

	​
	By: 
	 /s/ John Acunto

	​
	Name: John Acunto

	​
	Title: CEO

​
​

9
​

List of Exhibits
Exhibit A Documentation
Exhibit B FileWag Technology
Exhibit C Patent
Exhibit D Assignment of Patent Rights
​

10
​

EXHIBIT A & B
DOCUMENTATION & FILEWAG TECHNOLOGY
The FileWag documentation, code and technology have been provided via an Amazon image that will be made available via permissions to the nominated tsu/display Amazon account for transfer.
​

11
​

EXHIBIT C
PATENT
​

12
​

EXHIBIT D
ASSIGNMENT OF PATENT RIGHTS
WHEREAS, LookWithUs.com, Inc., a Delaware corporation ("Assignor") is owner of U.S. Patent Number: US 8,826,375 B2, dated September 2, 2014, titled Rich Media Collaboration System including the inventions described therein and the patents issued and reissued thereon (the “Patent”).
WHEREAS, Assignor and tsu Inc. (d/b/a display), a Delaware corporation, ("Assignee") entered into an Asset Purchase Agreement dated October 12, 2021 (the “Asset Purchase Agreement”) under which Assignor agreed to sell and Assignee agreed to purchase substantially all of the assets of Assignor including the Patent and the renewals therefor and all claims for past or future infringement thereof.
NOW THEREFORE, for good and valuable consideration, the receipt of which is hereby acknowledged, and intending to be legally bound, Assignor hereby sells, assigns, transfers and conveys to Assignee, its successors and assigns, free and clear of any and all liens, restrictions, claims and encumbrances, one hundred percent (100%) of its right, title and interest in and to the Patent for the entire term of the Patent and any reissues or extensions and for the entire terms of any patents, reissues, or extensions that may issue from foreign applications, divisions, continuations in whole or part, or substitute applications filed claiming the benefit of the Patent, together with all rights of registration, maintenance and protection thereof in any form, all rights to income, royalties, damages and payments now due or hereafter due or payable in respect thereto, and all rights of recovery and of legal action for past or future infringements and of interference proceedings and reexaminations involving such Patent. The right, title, and interest conveyed in this Assignment is to be held and enjoyed by Assignee and Assignee's successors and assigns as fully and exclusively as it would have been held and enjoyed by Assignor had this assignment not been made.
Assignor authorizes the United States Patent and Trademark Office and any other applicable jurisdictions outside the United States to record the transfer of the Patent to Assignee as the recipient of all of Assignor’s right, title and interest in and to the Patent.
Assignor further agrees, without any further compensation, to: (a) cooperate with Assignee in the protection of the patent rights and prosecution and protection of foreign counterparts; (b) execute, verify, acknowledge and deliver all such further papers, including patent applications and instruments of transfer; and (c) perform such other acts as Assignee lawfully may request to obtain or maintain the Patent and any and all applications and registrations for the invention described therein in any and all countries.
This Assignment of Patent Rights shall be construed, interpreted and applied in accordance with the laws of the State of New York, without regard to its conflicts of law principles.
Date: October 12, 2021
	Assignor: LookWithUs.com, Inc.
	​
	Assignee: tsu Inc. (d/b/a Display)

	​
	​
	​

	By:
	​
	​
	By:
	​

	​
	​
	​

	Print Name:
	​
	​
	Print Name:
	​

	​
	​
	​

	Title: 
	​
	​
	Title:
	​

​

13
​

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00344-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00344-of-00352.parquet"}]]